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ACID SECRETION IN THE MAMMALIAN STOMACH?
CHAPTER I 
INTRODUCTION
Secretion of hydrochloric acid by the stomach was first report­
ed by William Pront in 1824 and by Beaumont in the next decade (l833). 
Since then, the problems of formation and secretion of gastric acid have 
been subjected to a great deal of study with many hypotheses having been 
proposed. At present there exists no satisfactory picture of the meta­
bolic mechanism of acid secretion by the stcxnach.
Recently, Harris and his coworkers (1969) proposed an exciting 
hypothesis which describes the initial biochemical reactions involved in 
the secretory response of the frog stomach to secretagogues. This pos­
tulate is that gastric acid secretion is mediated by adenosine-3',5'- 
monophosphate, or cyclic AMP, which has been recognized as a unique in­
tracellular mediator of many hormones. This research was undertaken for 
two reasons: l) the hypothesis has the potential of providing an impor­
tant breakthrough in our comprehension of the subcellular events involved 
in gastric acid secretion; and 2) the hypothesis has not been validated 
in the raanmalian stomach.
2Mechanisms of Acid Secretion by the Stomach
The gastric mucosa transfers hydrogen ions from the plasma at a 
concentration of 10"^ mN to gastric juice at a concentration of 160 mN. 
Chloride ion is transported from the plasma at a concentration of 110 mN 
into gastric juice at concentration of 170 mN. There is a potential dif­
ference (PD) across the gastric mucosa, which varies among species, but 
the secretory side is always negative with respect to the serosal side. 
Therefore, it is obvious that both and Cl" ions are moved by uphill 
transport, the former against a vast concentration gradient, the latter 
against both concentration and electrical gradients.
Mammalian gastric mucosa is composed of several major secretory 
cell types: mucus producing cells, chief cells and parietal cells. The
gastric juice normally collected is a mixture of the outputs from these 
different cell types. The cell of origin of each major component of 
gastric juice has been well-established. Acid is secreted by parietal
cells (Bradford and Davies, 1950); pepsinogen, which later is activated
to pepsin, is derived from chief cells (Bowie and Vineberg, 1953); and 
mucus containing various glycoproteins is the product of mucus secreting 
cells. Besides these major components, electrolytes probably have their
origins in several types of cells. Apart from this, there is little in­
formation as to which cells secrete the various ions. The major electro­
lytes found in normal gastric juice include these ions: chloride (Cl"),
hydrogen (H"*"), sodium (Na^l, potassium (K"^ ) and traces of calcium, phos­
phate, bicarbonate, etc. Because the gastric juice has several sources, 
its composition is variable. However its approximate isosmolality with 
respect to the plasma is steadily maintained. During the course of se-
3cretion the concentrations of electrolytes in the juice have been found 
to be a function of the secretory rate of the stomach. At a low rate of 
secretion, gastric juice resembles an isotonic saline solution with a 
low concentration of K . At a high rate of secretion, Na is gradually 
replaced by H"*" as the major cation, while K"*" concentration is still main­
tained relatively constant.
Gastrophysiologists have long been intrigued by the variations 
in the ionic composition of gastric secretion. Hollander, influenced by 
earlier ideas of Pavlov, suggested a two-component hypothesis (Hollander, 
1932; 1952). The essential element of his thesis was that variation in 
gastric acid concentrations depends on changes in the proportion of two 
components, a pure acid portion from the parietal cells, and a nonacid 
or alkaline portion probably originating in the surface epithelial cells, 
the mucous cells of the neck, and/or the chief cells. Sodium has its 
sole source from alkaline secretions, whereas chloride exists in both 
acid and alkaline portions, but at higher concentration in the latter. 
When the acid secretory rate increases, the proportion of alkali de­
creases and so does the pH of the mixture. Although the existence of 
nonparietal secretions has been supported both by direct (Pevsner and 
Grossman, 1955; Hollander, 1963; Webster et jd., 1958; James and 
Pickering, 1949; Ihre, 1938) and indirect (Fisher and Hunt, 1950; Lifson 
et , 1943) evidence, the poor rectilinear relations between concen­
trations of secreted H"^ , Cl“ and Na"*” have been criticized. Several in­
vestigators demonstrated a curvilinear relationship in the region of 
high acid concentrations (Linde and Obrink, 1950; Gudiksen, 1950; Cooke 
and Grossman, 1965).
4Rosemann in 1907 suggested that the gastric glands extract a 
solution from plasma containing sodium chloride of constant concentra­
tion and convert a varying proportion of this solution to hydrochloric 
acid. The degree of conversion depends upon the intensity of the secre­
tory stimulation. Rosemann*s major point was that chloride was secreted 
at a constant rate independent of the increase of secretion. This 
observation was confirmed by Cooke and Grossman (l965) at the low rates 
of acid secretion. However, when acid concentration was greater than 
130 mN, the concentrations of acid and chloride varied together. This 
observation might be explained by the effect of dehydration, as Rosemann 
suggested (1907), or by an osmotic effect on the secretion, as pointed 
out by Durbin and Moody (l965). It should be noted that the key step in 
Rosemann's theory, namely conversion of NaCl to HCl was never elucidated.
Teorell proposed a "Diffusion Theory" in 1933 (Heinz and Obrink, 
1954). In this theory, the variation in acidity of the gastric juice 
depends upon a diffusion process. The primary secretion in gastric 
tubules, isosmotic with plasma, consists of constant concentrations of 
HCl and KCl. At low rates of secretion the back-diffusion of H"^  from 
lumen to plasma exceed that of Cl" owing to the differences in their re­
spective mobilities and the permeability of the mucosa to these two ions. 
In order to maintain electrical neutrality, Na"^  ions move into the lumen 
from plasma. The net result is ion exchange between H"^  and Na"*". The 
diffusion rate of H"*" will depend on the mucosal surface area, concentra­
tion and volume of gastric secretion and the degree of mixing. The cur­
vilinear relation between the concentrations of Cl" and predicted by 
this hypothesis was well supported (Linde and Obrink, 1950; Gudiksen,
51950; Cooke and Grossman, 1965). It has been shown (Davenport et al.. 
1964; Davenport, 1967), however, that in the gastric lumen does not 
penetrate the normal mucosa to any great extent in exchange for Na'*’.
Based upon the anatomical arrangement of the gastric glands in 
the mammalian stomach, Hirschowitz proposed a 4th explanation for the 
variations of ionic composition in gastric juice (Hirschowitz, 1960; 
Hirschowitz, 1961). He split the gastric secretory process into two 
mechanisms: primary and secondary. The function of the former is to se­
crete a solution containing Na'*’, K'*’ and Cl". The secondary mechanism is 
the exchange reaction of H'*’ for Na"*". In this respect, Hirschowitz's view 
resembles the one suggested by Rosemann (1907). Hirschowitz further con­
sidered that the gastric tubule comprises the basic unit of the mucosa, 
the gastron, which accomplishes both secretory mechanisms. He suggested 
that chief cells at the base of the gastric tubules are the site of ori­
gin of primary secretion. When this solution flows through the middle 
region of the tubule where the parietal cells are located, a varying 
proportion of Na'*' is exchanged for H'*'. This hypothesis has not yet been 
tested. Furthermore, only the mammalian gastric glands have both parie­
tal and chief cells. In the acid secreting stomach of other vertebrates, 
such as birds, reptiles, amphibians and fish, a single cell type, usually 
designated the "oxyntic" or "oxynticopeptic" cell functions as both the 
parietal and chief cell of mammals (ito, 1967).
In view of the preceding discussion, it is apparent that none 
of the hypotheses mentioned is able to explain fully the observed ionic 
variations of gastric juice in man and in animals. At present, it seems 
justifiable to say that after a pure acid juice is secreted from the
6parietal cells, it will be diluted or neutralized by some nonacid secre­
tions from another cell type. Some may diffuse across the mucosa in 
exchange for Na"^ . In some cases, contamination from saliva» duodenal 
content and food during the collection of gastric secretion also accounts 
for the variation of electrolyte content. In the futur®» a quantitative 
combination of two or more hypotheses might prove to be more Useful in 
understanding this problem.
In 1834, Donne first recorded a potential difference across the 
wall of the stcxnach. Success in developing two tissue preparations, 
namely the isolated frog mucosa by Delrue in 1930 and the chambered seg­
ment of canine stomach by Rehm in 1944, facilitated further research on 
the electrophysiology of the stomach.
Following the discovery of the gastric potent!®!, there was 
little agreement on its origin until 1951. Hogben (19^1) utilized the 
voltage clamp technique of Ussing and Zerahn (l95l) in the isolated frog 
mucosa. In this procedure, the natural potential difference across the 
mucosa was brought to zero by passing an external current through the 
membrane. In the absence of a concentration gradient, the intensity of 
the external current (or "short circuit current") needed for maintaining 
a zero potential reflected the net active transports of ions across the 
membrane. Combining these results with those obtained from isotopic flux 
studies (Hogben, 1955), Hogben was able to demonstrate conclusively that 
net transport of Cl~ in excess of secreted H"^  was responsible for the 
short-circuit current. In other words, the equivalents of net Gl~ trans­
port were the sum of short-circuit current and secreted H"*" ions. This 
conclusion was confirmed later by Forte et (1963) when they replaced
7all the Cl" in the salt solution bathing the isolated mucosa with another 
anion, isothionate, which is not readily secreted by the mucosa, the po­
larity of gastric potential reversed from the normal. This showed that 
the chloride pump is electrogenic and is necessary for the naturally oc­
curring potential difference across the mucosa. An important observation 
in the isotopic study made by Hogben (l95S) was that the leakage of Cl" 
back from the secretory side was more than twice that necessary to ac­
count for the total membrane conductance. Apparently, part of the Cl 
moving from the secretory to nutrient solution was nonconducting, prob­
ably in the undissociated state. This prompted the author to suggest 
his "carrier" hypothesis for chloride transport in the gastric mucosa 
(Hogben, 1955).
The secreting mucosa of the dog maintains a fairly constant 
spontaneous potential and a mucosal resistance which are relatively in­
dependent of the rate of H"^  secretion (Rehm and Hokin, 1948). The short- 
circuit current also does not depend on secretion. Similar observations 
have been reported for the isolated frog mucosa (Crane et al^ ., 1946).
As the mucosal short-circuit current is constant and independent of the 
rate of H^ secretion, variations in H"*" secretion demand corresponding 
variation in the rate of Cl" secretion. Thus the active transport of 
chloride is a part of the integral system of acid secretion.
The nature of the mechanism for Cl" transport is completely un­
known. Nevertheless, its wide range of specificity has been well docu­
mented by several research groups. Klilz first showed that the stomach 
secreted other halogens when they were introduced into the animal by in­
travenous injection (Külz, 1886). Lipschitz (l93l) found a higher accu­
8mulation ratio of gastric concentration and plasma concentration for 
iodide (I ) than for Cl" and bromide (Br”). Davenport's group (Davenport 
and Fisher, 1940; Davenport, 1943) showed that the concentrations of I" 
in the gastric juice were not dependent on the rate of secretion. Heinz 
et al. (1954) further studied the problem with cats by replacing plasma 
Cl with a wide range of Br" concentrations. The accumulation ratio of 
Cl between concentrations in gastric juice and plasma increased with in­
creasing Cl" concentrations in plasma, while the ratio of Er" decreased 
with a gradual increase of plasma concentrations. This different behav­
ior of Br" and Cl" in gastric secretion was attributed to their different 
affinities for a carrier material which was probably responsible for ac­
tive transport of anions in gastric cells. With a pure kinetic approach, 
Durbin studied the interaction between Cl“ and other anions such as Br",
I and thiocyanate in gastric acid secretion from isolated frog stomach 
(Durbin, 1964). He found that the relation between acid secretory rates 
and anion concentrations in nutrient solutions closely resembled 
Michaelis-Menten Kinetics. Lineweaver-Burk plots denoted a linear re­
lationship between acid secretion and permeable anion concentrations in 
bathing solutions.
This finding greatly strengthened the hypothesis that there is 
a membrane carrier for anion transport in gastric muî'osa- The affinity 
of Br" for the postulated carrier appeared strongest among the three 
halogens tested, with Cl" showing next high affinity (Durbin, 1964).
This means that the gastric mucosa transports Br" more readily than Cl".
Thiocyanate is known as an inhibitor of gastric acid secretion. 
In the Durbin study (l964) thiocyanate acted as a competitive inhibitor
9of Cl" transport. It is likely that thiocyanate ions compete with Cl" 
for the transport carrier. In the presence of high concentrations of 
thiocyanate, Cl" transport from nutrient to secretory side was greatly 
reduced, and H"*" transport was hindered owing to a lack of electrical bal­
ance.
Based upon the preceding discussion, it appears that Cl" is ac­
tively extruded from gastric cells into the lumen of the stomach. The
continuous source of Cl" is the circulating plasma which is hardly a
limiting factor under physiological conditions. When Cl" is secreted 
into the lumen, the plasma Cl" will tend to diffuse down the concentra­
tion gradient into the gastric cells (Forte et ad., 1963) and assure a 
constant supply of Cl" for transport.
In the case of secretion in the stomach, the situation is ob­
viously different. During the actively secreting state, H'*’ is secreted
into the stomach lumen with acid at a concentration of approximately 
160 mEq/l. Because a neutral pH must always be maintained in plasma and 
cells, the perpetually perplexing question for the gastrophysiologist 
has been how the gastric cells generate H'*' and actively transport H"*" 
against a million-fold chemical gradient. Numerous hypotheses have been 
proposed to meet the quandry in the past 150 years, but none satisfacto­
rily explained the problem.
In 1948, Conway and Brady (194B) first introduced a new concept, 
the "redox theory," for H"*" generation in the gastric cells. Similar pro­
posals by several other investigators followed almost immediately (Crane 
and Davies, 1948; 1948a; Davies and Ogston, 1950). Despite divergent 
views on the details, they concurred that production by the stomach
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involves an oxidation-reduction reaction at the surface of the parietal 
canalicular border.
According to this theory, atomic hydrogen in an energy-producing 
substrate is oxidized to produce H"*" by an electron acceptor. The is 
extruded out of the cell membrane bordering the gastric cavity. Mean­
while, the electron acceptor turns to the inner face of a membrane and 
delivers its carried electron to molecular oxygen. The oxygen is sub­
sequently reduced to hydroxyl ion (OH”). The hypothetical electron ac­
ceptor (or "metal catalyst" after Conway) could very well be a cyto­
chrome-like compound. The electron transferring sequence has not yet 
been proven. The electrons might be split off from the hydrogen atom 
and be accepted by some organic coenzymes such as DPN (diphosphopyridine 
nucleotide) or FAD (flavin adenine dinucleotide) prior to the involve­
ment of cytochrome materials (Conway, 1953).
The cellular respiratory process responsible for the liberation 
of H'*’ in acid secreting cells is probably not different from the conven­
tional cellular respiratory system except for the separation of two prod­
ucts of the process, H'*’ and OH” ions, instead of their combination to 
form water. This separation of positive and negative charges represents 
the crucial point of the redox theory (Robertson, I960).
How electrons move in the cytoplasm resulting in eventual ac­
ceptance by molecular oxygen remains controversial (Lundegardh, 1940;
Crane and Davies, 1948; Geissman, 1949; Chance and Williams, 1956;
Chance, 1959). It seems reasonable to speculate that the separation of 
h"*” and electrons occurs in a particular lipoid membrane in which the 
electron carriers might be arranged into close proximity with one another.
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Because of the low permeability of the membrane for H"*", H"*" once formed 
will be released into one side of the membrane while the electron passes 
through the array of carriers and finally combines with oxygen on the 
other side of the membrane to form OH" in the presence of water 
(Robertson, I960).
The mitochondrial membrane is likely to be the best locus for 
these reactions, since the electron transport system and the accompany­
ing oxidative phosphorylation are intimately associated with mitochondria. 
Strong suggestive evidence also comes from ultramicroscopic studies.
First, the parietal cells are particularly rich in mitochondria. Other 
indications are that the mitochondrial membrane is not always separated 
from other cellular membranes. Geren and Schmitt (l954) showed that the 
mitochondria in a lobster nerve could connect with the axon surface of 
the Schwann cell. If this should also be the case in the parietal cell, 
the produced H"*" in the mitochondria may be transported through the con­
nection to the openings of the secretory surface in the canaliculi 
(Robertson, I960). This possibility is attractive and should be subject­
ed to further investigation.
It seems clear now that a Cl" pump is responsible for the PD 
across the gastric mucosa and constantly transports Cl" from serosal to 
secretory side. A question thus arises: Is the favorable electric po­
tential set up by the Cl" pump the driving force fcr H"*” secretion? The 
answer was given in the work of Heinz and Durbin (l959). They replaced 
all Cl" in the nutrient solution bathing an isolated frog mucosa with 
sulfate ion which is not actively transported by the tissue. They found 
that H'*’ secretion was maintained at about two-thirds of the normal rate.
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Furthermore, the PD was reversed in sign and the short-circuit current 
displayed characteristics of an active H"*" pump. Therefore, H"*" can be ac­
tively transported by gastric mucosa independent of Cl" secretion. This 
conclusion was supported by Shanbour and Rehm (l97l).
In 1859, Brlicke assumed that if an acid was liberated in the 
gastric tubules, an alkaline fluid of corresponding strength must be 
elaborated simultaneously in the opposite direction into the blood 
(Davies, 1948). This assumption has subsequently been proved correct by 
many investigators (Bulger ^ . , 1928; Hanke et ^ . , 1931; Gray et al.. 
1940; Teorell, 195l). Furthermore, it was noted that carbon dioxide 
(CO2) is essential for normal acid secretion because of its ability to 
form a buffer system in the parietal cells and to neutralize the OH" left 
behind during acid secretion. It has been repeatedly shown with isolated 
frog gastric mucosa that, in the absence of external supplies of CO2, 
acid is secreted at greatly reduced rates (Delrue, 1933; Gray and Adkison, 
1941; Davies and Longmuir, 1948; Weaver, 1951; Hogben, 1953). Similar 
results have been demonstrated in intact animals (^perly and Crabtree, 
1931; Browne, 1932; Fürst, 1950). In vitro, ulceration and perforation 
were observed in the mucosal tissue if the rate of acid secretion was 
high (Davies and Longmuir, 1948). These observations provided evidence 
that CO2 produced by gastric metabolism during acid secretion is stoi- 
chiometrically insufficient for neutralization of alkali within the se­
cretory cells.
It has been known for years that the uptake and release of CO2 
in blood cells are catalyzed by an enzyme, carbonic anhydrase. This en­
zyme is capable of catalyzing the reaction, CO2 + H2O H2CO3.
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Davenport and his coworkers showed that carbonic anhydrase exists in very 
high concentrations in the parietal cells (Davenport, 1939; 1940). This 
observation implies, but does not guarantee, that this enzyme does ac­
tively function in acid secreting cells. It is now believed that carbonic 
anhydrase in the parietal cells catalyzes the formation of carbonic acid 
which dissociates into and bicarbonate (HCOg"). H"*” derived from this 
reaction is used for neutralizing the OH" produced in the acid secretory 
process, while HCOg" diffuses across the serosal membrane of the parietal 
cells into the blood and causes the "alkaline tide" (Hanke et al., 1931). 
Because carbonic anhydrase exists at such a high level in the parietal 
cells, a very high degree of inhibition of the enzyme is necessary to 
hinder acid secretion (Davies and Houghton, 1948). This inhibition has 
been shown both in vitro (Davenport and Jensen, 1948; Davies et al..
1951) and in vivo (Janowitz, 1952) with various carbonic anhydrase inhi­
bitors. Today, the carbonic anhydrase system in the parietal cells has 
been recognized as a protective acid-base balance measure against damage 
from the alkaline by-product of acid secretion.
Cellular respiration is critical for acid secretion. %n vitro, 
the lack of an oxygen supply or use of specific inhibitors of respira­
tion cause immediate cessation of acid secretion (Crane et , 1946; 
Davenport, 1947). A linear relationship between acid secretion and O2 
consumption by gastric tissue has been well-established. The efficiency 
of acid secretion in terms of the molar ratio of H'^ /02 has received much 
recent attention. This ratio has particularly interested the gastro­
physiologists because it is directly related to the basic assumption of 
the redox hypothesis of acid formation. As discussed previously, with
14
every H"*" generated from atomic hydrogen of a substrate precursor, one 
electron is concomitantly released into the electron carriers and even­
tually transferred to O2. One molecular O2 can theoretically take up 
4 electrons and be reduced to 4 0H“ in the presence of water. In other 
words, there will be 1 molecule of O2 consumed for every 4 free H'*’. How­
ever, so far, a wide range of values has been found by different investi­
gators (Crane and Davies, 1948; Davies and Ogston, 1950; Davies and 
Houghton, 1948; Teorell, 1949; Davenport and Chavre, 1952; Davenport, 
1952; Davenport and Chavre, 1953). This great discrepancy may be attri­
buted to the difficulties in measuring O2 consumption (Davies, 1957), 
differences in experimental conditions (Forte and Davies, 1963) and prob­
ably the heterogeneity in the cellular composition of mucosal tissue.
This controversy is largely unsettled. Nevertheless, the experimental 
evidence seems generally to arrive at a ratio of about 2, although a 
ratio higher than 4 would not necessarily exclude a redox pump (Hogben, 
1960).
Since O2 supply is absolutely required for sustained acid secre­
tion in in vitro preparations, the acid secretory process appears to de­
pend upon aerobic metabolism of the parietal cells. Davenport and Chavre 
(1952) reported that at low partial pressures of O2, the average ratio 
of H"*" secreted to O2 consumed increased. They concluded that anerobic 
glycolysis can also contribute energy to a certain extent for acid secre­
tion under such a circumstance. Many substances are capable of stimulat­
ing acid secretion in vitro, such as glucose, acetoacetate (Davenport 
and Chavre, 1951), lactate and pyruvate (Davenport and Chavre, 1950), and 
fatty acids (Alonso ^  al_., 1967). But none of these materials have been
15
shown to be essential for acid secretion. The hypothesis that the acid 
secretory process depends on the mediation of energy-rich phosphates was 
supported by evidence that azide and 2,4-dinitrophenol, which were known 
to interrupt the coupling of oxidative phosphorylation, inhibit acid se­
cretion without affecting the O2 uptake (Davenport and Chavre, 1953; 
Davies, 1951). Forte et al^ . (l965) studied the ATP content in bullfrog 
gastric mucosa. They found a substantial correlation between the rates 
of acid secretion and the concentrations of ATP in the mucosa. Thio­
cyanate inhibited acid secretion but had no effect on ATP content of
mucosa (Forte et al., 1965). It is interesting to compare this latter 
finding with the experiments done by Kasbekar and Durbin on gastric 
adenosine triphosphatase (ATPase). Kasbekar and Durbin reported (l965) 
a membrane-bound ATPase from bullfrog gastric mucosa. This enzyme has 
distinct characteristics from other ATPases related primarily to Na"^  and 
K"*” transport. Gastric ATPase was stimulated by HCO3" and halide ions 
but reversibly inhibited by thiocyanate ions. Therefore the results sup­
ported the view of Forte et (l965) that thiocyanate inhibits acid 
secretion by preventing the utilization of ATP by the secretory mechanism. 
Based upon the experimental observation, Durbin and Kasbekar (1965) put 
forward an ATPase hypothesis which includes ATPase as an integral part
of the HCl secretory mechanism. Like other hypotheses, it is supported
but unproven.
In summary, the mechanism of acid secretion in stomach is un­
clear. What we can be certain of is that the formation of hydrochloric 
acid is the result of the active transport of two ions, H"^  and Cl". The 
transport processes of and Cl” can be independent of one another, but
16
during acid secretion they normally operate in parallel. Water seems to 
be pulled into the lumen by a passive force, an osmotic gradient estab­
lished by active transport of H'*' and Gl". It is not known how the two 
ionic transports interrelate during acid secretion. The nature of the 
transport mechanisms for two ions are likewise obscure. Rehm ^  al. 
argued that and Cl” may be secreted from different cellular origins, 
probably surface epithelial cells for and parietal cells for Cl”
(Rehm et âi-» 1953). This hypothesis is unlikely (Davies, 1957) and 
there is strong evidence suggesting that ionic transport responsible 
both for electrical and acid secretory phenomena originates in the pa­
rietal cells (Davenport and Allen, 1959; Durbin and Kasbekar, 1965). Ac­
tive transport processes require energy. For acid secretion, high energy 
phosphate bonds may play a central role. However how this high energy 
producing system is geared into the ionic transport mechanism remains an 
interesting subject for future investigation.
The Biochemistry of Adenosine 3'.5'-Monophosphate
(Cyclic AMP)
While investigating the effect of catecholamines and glucagon 
on the activation of liver phosphorylase. Rail, Sutherland, and Berthet 
(1957) discovered a heat-stable factor capable of stimulating the conver­
sion of inactive phosphorylase to its active form. This factor was de­
tected in the presence of either epinephrine or glucagon in the "boiled 
extract" of an incubation mixture which included the low-speed particu­
late fraction of liver homogenate, adenosine triphosphate (ATP) and mag­
nesium ions. In the absence of epinephrine and glucagon, the "boiled 
extract" had little effect on phosphorylase activation. The response to
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the hormones in liver homogenates could be separated into two phases:
(l) the formation of an active factor in particulate fractions in the 
presence of epinephrine or glucagon, and (?.) the stimulation of homoge­
nates by liver phosphorylase in the supernatant fractions, in which the 
hormones themselves had no effect. At the same time. Cook et jd. (l95V) 
independently reported finding a new product during hydrolysis of ATP in 
the presence of barium hydroxide. Subsequent studies showed the new sub­
stances reported by both groups of investigators to be identical, 
(Sutherland and Rail, 1957; 1958) with a structure of a mononucleotide 
of adenylate with a phosphate group esterified at carbons 3’ and 5' of 
the ribose moiety. Therefore, it was given the name of adenosine 3',5'- 
monophosphate, or cyclic AMP. The structure was later confirmed by the 
use of a variety of enzymatic and chemical degradations, as well as di­
rect determination of molecular weight with ultracentrifugation (Lipkin 
et , 1959). Cyclic AMP proved not only to be stable during 30 min­
utes of boiling, but to be dialyzable and resistant to acid and alkali 
(Sutherland and Rail, 1958). Not long afterward, two enzymes were dis­
covered which directly influenced the level of cyclic AMP in tissues: 
adenyl cyclase and cyclic nucleotide phosphodiesterase.
Adenyl Cyclase
Adenyl cyclase is widely distributed in nature, having been 
found in all animal tissues studied to date and in a variety of unicellu­
lar organisms— the possible exception being canine red blood cells 
(Klainer ^  al., 1962). In all cases, the enzymic activity seems to be 
restricted to low-speed particulate fractions. In addition, most of the 
activity has been associated with the plasma membrane (Davoren and
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Sutherland, 1963; 0ye and Sutherland, 1966; Pohl et al., 1969; Birnbaumer 
and Rodbell, 1969). A soluble adenyl cyclase has been identified in 
Brevibacterium liauefaciens (Hirata and Hayaishi, 1967), although its ex­
act location within the intact bacterium remains uncertain.
Adenyl cyclase catalyzes the formation of cyclic AMP from ATP. 
The cofactor known to be required for this reaction is a divalent cation. 
Magnesium may be the natural cofactor, but manganese is also effective 
(Sutherland et ^ . , 1962). Pyrophosphate is formed stoichiometrically 
with cyclic AMP in cell-free systems.
The chemical structure of adenyl cyclase is poorly understood. 
Sutherland and his coworkers (l962) suggested that it might be a lipopro­
tein, based on their finding that the enzyme could be solubilized from 
the particulate fractions of mammalian cerebral cortex, heart, skeletal 
muscle, and liver with a detergent, Triton. Generally, adenyl cyclase 
activity has been found to be highly labile, especially in highly con­
centrated salt solutions (e.g., KCl) or in sucrose solution. However, 
when the particulate extract is prepared in hypotonic solution, consider­
able activity is retained for long periods after freezing and storage at 
-20°C or -70°C. The particulate preparation has also been lyophilized 
to dry powder form and stored jji vacuo in the cold with full retention 
of activity (Sutherland ^  al_., 1962). Nevertheless, due to its partic­
ulate nature and lability, adenyl cyclase has proven extremely difficult 
to purify and characterize extensively.
The adenyl cyclase systems in some tissues exhibit specific and 
sensitive responses to a variety of hormones. There are two alternative 
explanations for this: either (l) the different hormones stimulate a
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single enzyme via different receptors, or (2) a separate adenyl cyclase 
exists for each of the hormones. Birnbaumer et al_. (l970) studied the 
hormonal specificity In fat-cell ghosts with the four most active lipo­
lytic hormones: corticotrophin (ACTH), epinephrine, secretin, and glu­
cagon. They reported that propanolol, a beta-adrenergic blocking agent, 
inhibited the stimulatory activity of epinephrine but failed to affect 
that of ACTH or glucagon. DOB [l-(2,4-dichlorophenyl)-l-hydroxy-2(t- 
butylamino)ethane], a beta-adrenergic agent, stimulated adenyl cyclase, 
but its effect was not additive with the effect of epinephrine. An ACTH 
analogue inhibited only the stimulatory action of ACTH. Pretreatment of 
the adipose tissue with trypsin completely deprived glucagon of its stim­
ulating effect, caused partial loss of ACTH and secretin activity, and 
failed to affect epinephrine and fluoride activity. Judging from these 
observations, the authors concluded that a single adenyl cyclase system 
exists in adipose tissue, with distinctive and specific receptors or 
binding sites for different hormones. A single adenyl cyclase system 
with different receptors has also been postulated for many other tissues, 
such as cat liver (Makman and Sutherland, 1964), rat heart (Murad and 
Vaughan, 1969), and cat heart (Levey and Epstein, 1969).
In all adult mammalian tissues studied thus far, fluoride has 
been reported to stimulate adenyl cyclase very effectively in broken-cell 
preparations. Unlike hormones, fluoride apparently lacks selectivity in 
enhancing adenyl cyclase activity in different tissues. In 1958, Rail 
and Sutherland attributed the fluoride effect on cyclic AMP formation in 
dog liver homogenate to the maintenance of substrate concentration (ATP) 
by inhibition of ATPase (Rail and Sutherland, 1958). Later, they sug­
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gested that fluoride also stimulates adenyl cyclase activity (Sutherland 
et al., 1962). Although the stimulatory effect of fluoride on adenyl 
cyclase in broken-cell preparations may sometimes be striking, it has not 
been demonstrated in any intact tissues. The nature of fluoride stimula­
tion in broken-cell preparations, as well as the failure of fluoride to 
stimulate adenyl cyclase in intact cells, are unexplained at present.
The two events appear related, so that an answer to one question might 
help clarify the other.
In some tissues, combinations of maximally stimulating concen­
trations of hormones and fluoride do not produce additive effects, indi­
cating that only one adenyl cyclase system is affected. For example, in 
fat-cell ghosts, fluoride does not potentiate the maximal stimulating ef­
fect of lipolytic hormones on cellular cyclic AMP formation (Birnbaumer 
and Rodbell, 1969). When the incubation conditions were varied, 
Birnbaumer and Rodbell were able to show several differences between the 
effects produced by fluoride and by the homrones upon the enzyme. Their 
results suggested that hormones and fluoride activate a single enzyme 
through different processes. On the other hand, both fluoride and nor­
epinephrine activate adenyl cyclase in pineal homogenates, with many 
shared characteristics apparent. Nevertheless, norepinephrine plus 
amounts of fluoride that are in themselves maximally effective have been 
shown to further increase the rate of cyclic AMP formation (Weiss, 1969). 
This indicates that either (l) fluoride and norepinephrine activate sep­
arate catalytic sites of a single enzyme, or (2) two stimulants increase 
the activity of two enzymes in the pineal gland.
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Cyclic Nucleotide Phosphodiesterase
Like adenyl cyclase, phosphodiesterase is widely distributed in 
nature. This enzyme is known to hydrolyze cyclic AMP at the 3' position, 
thereby producing 5'-AMP. Divalent metal ions are also essential for the 
activity of the enzyme. The conversion of cyclic AMP to 5'-AMP by phos­
phodiesterase is the only well-known physiological mechanism for termi­
nating the action of the cyclic nucleotide. The existence of this enzyme 
was first demonstrated by Sutherland and Rail (l958) in the beef heart.
In addition to being identified in mammalian tissues, the enzyme has been 
detected in many unicellular organisms, such as yeast (Cheung, 1966), a 
bacterium (Brana and Chytil, 1966), and slime mold (Chang, 1968), as well 
as in several marine organisms (Yamamoto and Massey, 1969). The only 
cells to date which have been shown to lack the enzyme are avian erythro­
cytes (Drummond and Perrott-Yee, 1961). All mammalian tissues examined 
have shown cyclic nucleotide phosphodiesterase activity. The highest ac­
tivity has been measured in brain tissue (Drummond and Perrott-Yee, 1961; 
Butcher and Sutherland, 1962).
The subcellular distribution of phosphodiesterase activity in 
mammalian tissues has been demonstrated in both soluble and particulate 
fractions (2500 x g). The particulate fractions of homogenates of the 
various canine tissues vary in activity, ranging from ICP^  to 90^ of the 
total activity initially present in crude homogenates (Butcher and 
Sutherland, 1962). The characteristics of the particulate activity in 
all cases were almost identical with those of the soluble form. Butcher 
and Sutherland (l962) carried out the fractionations of phosphodiesterase 
activity in beef heart with ammonium sulfate and DEAE (Diethylaminoethyl)
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cellulose. They were able to purify the soluble enzyme 153-fold. Most 
of the work on the properties of phosphodiesterase has been done with the 
soluble enzyme.
In contrast to adenyl cyclase, phosphodiesterase is a stable 
enzyme. Storage at -20"C for a month usually causes no appreciable 
changes in activity. Divalent cations are absolute requirements for
-|-j-
full enzymic activity in all tissues studied. Mg and Mn are most
effective; other divalent ions, such as Co"*~^ , Ni"^, and Ba"*~^ , meet the
requirement much less effectively. Some divalent ions, like Ca , Cu ,
Hg"'”*’, and Zn"*"^ , may actually be inhibitory (Cheung, 1967; 1970). EDTA
completely abolishes the enzymic activity, although activity can be fully
“H" + +restored by the addition of Mg or Mn Based upon these findings, 
Cheung suggested that the active form of phosphodiesterase might be a 
metal-enzyme complex (Cheung, 1967). Phosphodiesterase from most tissues 
has a pH optimum between 7.5 and 8.0. In exceptional cases, such as the 
enzymes from dog heart (Nari, 1966) and fish brain (Yamamoto and Massey, 
1969), the pH optimum ranges between 8.5 and 9.0.
The molecular structure of phosphodiesterase is unknown. The 
only identifying clue comes from experiments using p-hydroxymercuriben- 
zoate and beta-mercaptoethanol. The former inhibits enzymic activity 
whereas the latter reverses the inhibition, seeming to indicate that 
phosphodiesterase possesses sulfhydryl groups essential for enzymic ac­
tivity. The molecular weight of phosphodiesterase has not been firmly 
established, although a value of approximately 300,000 is suggested by 
the data of several investigators studying different tissues (Cheung, 
1970; Chang, 1968; Menahan e_t ^ . , 1969).
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Cheung (l969) was able to resolve the enzymic activity into two 
active interconvertible peaks on a Sepharose 4B column. The first peak, 
of seemingly higher molecular weight, apparently consisted of the mole­
cules of phosphodiesterase aggregated by intermolecular disulfide link­
ages. The second peak, with a smaller molecular weight, probably con­
tained the reduced enzyme with the sulfhydryl groups. On the other hand, 
trypsin was found to activate purified phosphodiesterase and to reduce 
the molecular weight from the value determined before treatment with 
trypsin. Since molecular size could be changed under different condi­
tions, Cheung (l970) proposed that phosphodiesterase may be composed of 
subunits giving rise to different subunit structures and thus different 
molecular weights under varying conditions.
The Michaelis-Menten constant (K^ ) of phosphodiesterase has 
varied in the different tissues studied. At least in the brain tissues 
of some animals, two different values have been reported (Brooker 
et al.. 1968; Cheung, 1970). Whether the two values represent two 
species of the enzyme or both values apply to a single species is un­
known.
Many substances are known to inhibit phosphodiesterase activity. 
Butcher and Sutherland (l962) first demonstrated the inhibitory effects 
of the methylxanthines, such as theophylline, caffeine, and theobromine. 
In addition, papaverine inhibits phosphodiesterase activity (Kukovetz 
et al.. 1969; O'Dea et al., 1970; Triner et al_., 1970). Since methyl- 
xanthines are not readily metabolized in tissues, they have been used ex­
tensively in endocrine studies in which cyclic AMP is believed to play a 
role. However, phosphodiesterase from a slime mold (Chang, 1968) and
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Escherichia coli (Brana and Cytil, 1966) was not inhibited by caffeine 
and only slightly inhibited by theophylline.
A rat brain phosphodiesterase was also inhibited by pyrophos­
phate, several nucleotide triphosphates (including ATP), and some inter­
mediate organic acids in the citric acid cycle (Cheung and Salganicoff, 
1966; Cheung, 1967). The strong inhibition by ATP and pyrophosphate at 
approximately physiological concentrations prompted the speculation that 
phosphodiesterase might exist in vivo in a greatly inhibited state 
(Cheung, 1966). In addition, the activity of the enzyme was largely de­
pressed upon purification. Based upon his pioneering work, Cheung sug­
gested that the loss of activity was due to removal of a protein cofactor 
from the enzyme during the purification process (Cheung, 1970). A par­
allel distribution of phosphodiesterase and its protein cofactor was in­
dicated by subcellular fractionation of bovine brain cortex, cerebellum, 
hypothalamus, and other tissues. Phosphodiesterase cofactor has also 
been isolated from rat, porcine, and human brain and bovine heart. 
Cross-activation studies have shown that the activators (or cofactors) 
lack tissue specificity. On the basis of jri vitro studies, apparently 
the activity of phosphodiesterase can be regulated by three distinct fac­
tors: triphosphate nucleotides, divalent metal ions, and the protein ac­
tivator of the enzyme. The importance of these individual factors in 
the control of phosphodiesterase activity and their interaction in in 
vivo systems remains to be elucidated.
Biological Importance of Cyclic AMP
Since the discovery of cyclic AMP in 1957, many investigators 
have demonstrated it to be an extremely versatile agent. Not only has
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this simple nucleotide been implicated in numerous cellular functions, 
it has been established as a unique intracellular mediator of a wide va­
riety of hormones. A few hormonal actions mediated by cyclic AMP have 
been successfully studied at the level of enzymic activities— a well 
known example being phosphorylase activation by glucagon and epinephrine 
in the liver and by epinephrine in muscle. These hormones appear to 
stimulate adenyl cyclase in liver and muscle to increase cellular cyclic 
AMP formation. This increased cyclic AMP level initiates a "cascade" ef­
fect on activation of an enzyme system. In the liver, cyclic AMP is 
known to convert an inactive enzyme, phosphorylase-b-kinase, to its ac­
tive form. This active kinase catalyzes subsequent activation of phos- 
phorylase-b to phosphorylase-a (Sutherland and Robison, 1966). Krebs 
et al. (l966) presented evidence that increased cyclic AMP formation in 
skeletal muscle by epinephrine and glucagon stimulated a particular re­
ceptor earlier than phosphorylase-b-kinase. That receptor may be another 
kinase which is responsible for phosphorylation of phosphorylase-b-kinase.
Glycogen synthetase and phosphofructokinase are two additional 
enzymes whose relationship to cyclic AMP has received detailed attention. 
Glycogen synthetase exists in two forms: one is dependent upon glucose-
6-phosphate (the D form), and the other is independent of glucose-6-phos- 
phate (the I form). The inactivation of glycogen synthetase from the I 
to D form is catalyzed by a kinase, which is under the control of cyclic 
AMP (Huijing and Larner, 1966; Dewuff and Hers, 1968; Bishop and Larner, 
1969). Phosphofructokinase is a key enzyme in the glycolytic process.
In some species, at least, it may exist in both the active and inactive 
forms. The activation of this enzyme absolutely requires the presence
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of cyclic AMP. A kinase probably also participates in the activation of 
phosphofructokinase, with cyclic AMP stimulating the process through reg­
ulation of the kinase activity (Mansour, 1966; Stone and Mansour, 1967). 
Furthermore, cyclic AMP antagonizes the inhibitory effect of ATP on the 
activated phosphofructokinase. This effect of cyclic AMP may also con­
tribute to the activation of phosphofructokinase (Stone and Mansour,
1967).
The precise mechanisms whereby cyclic AMP influences many hor­
monal functions are unknown. Ignorance of discrete biochemical reactions 
extends even to those biological processes which have been shown to be 
mediated by cyclic AMP, such as lipolysis in adipose tissue in response 
to various hormones (Vaughan and Steinberg, 1965), steroidogenesis in ad­
renal gland and corpus luteum in response to ACTH and the gonadotrophins 
(Hilf, 1965; Marsh et ^ . , 1966), thyroid hormone production stimulated 
by TSH (Gilman and Rail, 1966; Ensor and Munro, 1967), and positive ino­
tropic response of the heart to catecholamines (Sutherland et al., 1968).
In order to identify cyclic AMP as an intracellular mediator of 
any given hormone, Sutherland and his collaborators have proposed four 
essential criteria, which can be established by four types of experiments. 
Specifically, (1) adenyl cyclase in broken-cell preparation should re­
spond to the same hormone which is effective in the intact tissue; (2) 
the level of cyclic AMP in intact tissue should change appropriately in 
response to hormonal stimulation; (3) the hormone which stimulates adenyl 
cyclase should be potentiated by drugs which inhibit phosphodiesterase 
activity, such as theophylline and caffeine; and (4) the hormonal effect 
may be mimicked by exogenous cyclic AMP (Sutherland et , 1968).
27
Many hormones appear to be part of a two-messenger system 
Sutherland et , 1968). According to this concept, the hormones act­
ing as the first messengers travel from their cells of origin to the tar­
get tissues where they stimulate membrane-bound adenyl cyclase to promote 
the formation of intracellular cyclic AMP. The increased concentration 
of cyclic AMP then activates special cellular mechanisms responsible for 
particular physiological responses, according to the characteristics of 
the cells involved. Cyclic AMP receives the biological signals coming 
from the hormones (the first messengers) and transmits them to the cellu­
lar machinery to produce hormonal effects in the cells. This two-messen­
ger concept assumes cyclic AMP to be the second messenger.
Despite a poor understanding of the mechanisms of action of cy­
clic AMP in most hormonal functions, the discovery of the participation 
of cyclic AMP in hormonal processes does seem to lead us one step closer 
to understanding how hormones influence their target tissues.
Effect of Cvclic AMP on Gastric Mucosa
Although cyclic AMP has been intensively studied in a number of 
mammalian tissues, especially in muscle, liver and brain, little is known 
about the role of the nucleotide in gastric secretory processes.
Orloff and Handler (l962) observed that cyclic AMP and theophyl­
line mimicked the hormonal effect of vasopressin on the toad bladder in 
vitro. Each agent caused an increase in the permeability of toad bladder 
to water and in the rate of active transport of sodium (expressed in a 
change of the short circuit current).
In cooperation with Butcher and Sutherland, they further demon­
strated that incubation with either arginine-vasopressin or theophylline
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resulted in a significant increase in the concentration of cyclic AMP in 
the toad bladder and that vihen the two agents were employed together, a 
synergistic effect on the increase in cyclic AMP level was apparent 
(Handler et , 1965). The results of these experiments supported their 
original hypothesis that cyclic AMP is the intracellular mediator of the 
effects of vasopressin. The effect of theophylline on ion transport in 
toad bladder was interpreted as inhibition of phosphodiesterase, thereby 
increasing cyclic AMP levels.
The discovery that cyclic AMP participates in producing the ef­
fect of vasopressin on sodium and water transport in toad bladder was the 
first evidence that the cyclic nucleotide plays a part in ion transport 
across cell membranes. The pioneering work of Orloff and Handler essen­
tially initiated the subsequent studies of cyclic AMP effects on acid se­
cretion in the stomach.
Harris and Silen (l964) reported that imidazole largely inhib­
ited spontaneous acid secretion from isolated frog gastric mucosa and 
depressed acid secretion by more than half during stimulation with hista­
mine in the same preparation. Intravenous infusion of imidazole in a 
dog with a Heidenhain pouch also significantly decreased acid secretion 
during constant histamine stimulation (Harris and Silen, 1964). Subse­
quently, imidazole was shown not only to inhibit histamine-stimulated 
acid secretion from isolated frog mucosa but also to reduce active so­
dium transport by toad urinary bladder (Alonso et , 1965). The in­
hibitory effect of the imidazole on acid secretion could not be ascribed 
to its buffering capacity or to competitive inhibition of histamine 
(Harris and Silen, 1964; Alonso e_t a^., 1965). Since imidazole was found
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in vitro to stimulate the phosphodiesterase that inactivates cyclic AMP 
(Sutherland and Rail, I960), the effect of imidazole on ion transport 
may be related to declining concentrations of intracellular cyclic AMP.
In another investigation, Alonso and Harris drew attention to 
the effects of methylxanthines on isolated frog gastric mucosa (Alonso 
and Harris, 1965). Their results indicated that all three methylxan­
thines studied (theophylline, theobromine and caffeine) were capable of 
increasing acid secretion from the intact isolated mucosa and of in­
creasing oxygen consumption in the minced mucosal tissue, provided that 
the bathing solutions contained chloride ions. Theophylline was the 
most potent of these three compounds in stimulating acid secretion and 
oxygen consumption. Both theophylline and histamine produced a large in­
crease in mucosal short circuit current which preceded the rise in H"*" 
transport and declined as the H"*" flow began to increase. On a molar 
basis, the mucosa was less sensitive to theophylline than to histamine. 
However, at both maximally effective concentrations, theophylline yielded 
a significantly greater response than histamine (Alonso and Harris, 1965). 
The significance of this finding is unclear.
Because the methylxanthines appeared to affect both acid secre­
tion and metabolic rate concomitantly, a causal relation between these 
two responses was suspected. In an attempt to dissociate secretory and 
metabolic responses to supposed increases in cyclic AMP, Alonso and 
Harris substituted an impermeant ion, glucuronate, in the solution bath­
ing the jj2 vitro frog submucosal surface. They found that oxygen con­
sumption of the tissue remained unchanged even with histamine or caffeine 
which stimulated oxygen consumption when chloride was present (Alonso
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and Harris, 1965). Durbin (1964) previously showed that substitution of 
glucuronate for chloride in the bathing solution essentially eliminated 
both H"*” flow and short circuit current. Therefore, it seems that hista­
mine and the methylxanthines act primarily on the ion transport process, 
and the increase in oxygen consumption appears secondary to ion secre­
tion.
Since both methylxanthines and imidazole directly influence cel­
lular concentrations of cyclic AMP, the results of the preceding experi­
ments suggested a role for cyclic AMP in acid secretory function. In or­
der to obtain more evidence for this hypothesis, Harris and Alonso ex­
amined the effect of exogenous cyclic AMP on isolated frog mucosa bathed 
with solutions containing either chloride or glucuronate (Harris and 
Alonso, 1965). With chloride in the bathing solution, cyclic AMP in­
creased acid secretion in the mucosa from one species of frogs, but fail­
ed to evoke secretion in the mucosa of another species. In the second 
species, however, cyclic AMP impeded the natural decline in secretion 
that occurred in untreated mucosa during incubation. The replacement of 
chloride solution on the submucosal side with glucuronate solutions re­
sulted in either complete cessation or great reduction of H"*" flow, even 
with cyclic AMP in the bathing solutions. Beside the secretory effect, 
cyclic AMP exerted a profound influence on the tissue metabolic rate.
With both glucuronate and chloride solutions, cyclic AMP significantly 
increased oxygen consumption of the mucosal tissue. The latter finding 
suggests that cyclic AMP affects cellular metabolism independent of H'*’ 
and Cl“ transport. In other words, it may be possible that cyclic AMP 
primarily affects metabolic activity in the mucosa and increases secre­
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tion only secondarily or that cyclic AMP could cause separate effects on 
metabolism and membrane transport of hydrochloric acid (Harris and 
Alonso, 1965). It is not surprising that cyclic AMP should be related 
to energy metabolism in the secretory stomach, since the nucleotide plays 
a documented role in carbohydrate and lipid catabolism in many tissue 
(Robison et al.., 1968).
In frog gastric mucosa, Nigon and Harris (l96S) found that ex­
ogenous cyclic AMP did not stimulate but only inhibited the decline in 
phosphorylase activity observed during the incubation. However, in an­
other investigation (Alonso et al., 1968), cyclic AMP significantly in­
creased glycogenolysis in mucosa incubated in chloride solutions and to 
a lesser degree in glucuronate solutions. Therefore, the authors con­
cluded that the small changes in phosphorylase activity shown previously 
were physiologically important.
The difference of magnitude in glycogenolysis in two solutions 
was similar to the difference in oxygen consumption of mucosal tissues 
incubated with chloride versus glucuronate during addition of cyclic AMP. 
From these results Alonso et ajL. (l968) suggested that cyclic AMP may 
have a direct effect on glycogenolysis that is not tightly coupled to the 
effect on acid secretion.
According to their calculation, Alonso et al. (l968) reported 
that only half of the measured oxygen consumption could account for gly­
cogen utilization either in the mucosa exposed to cyclic AMP or the un­
treated mucosa. This implies that carbohydrate is not the only energy 
source for gastric mucosa. Their hypothesis is compatible with previous 
observations that fatty acids or triglycerides also provide energy for
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acid secretion (Alonso ^  al_., 1967). Thus, it is likely that cyclic 
AMP may accelerate both lipid and carbohydrate metabolism in gastric mu­
cosa. A part of the energy increment would be devoted to ion transport 
processes. Most recently Harris' group reported a relationship between 
cyclic AMP and gastric acid secretion which was noted when theophylline 
was incubated with frog mucosal tissues; tissue cyclic AMP concentration 
measured by a method based on phosphorylase activation was significantly 
increased. There were two strong arguments supporting the hypothesis: 
first, the concentration of methylxanthines that affect acid secretion 
correlated remarkably with the concentrations used to increase the mu­
cosal cyclic AMP level; second, the increase in tissue cyclic AMP in re­
sponse to theophylline paralleled the rise in acid secretion as far as 
the time course was concerned (Harris et , 1969).
The results with isolated frog gastric mucosa may be summarized 
as follows: There is strong evidence that cyclic AMP is involved in gas­
tric acid secretion in frog stomach. The mechanism by which cyclic AMP 
regulates gastric acid secretion and the relation of enhanced metabolic 
activity to secretory processes is uncertain. Furthermore, a question 
raised by Harris' experiments remains unanswered. If the secretory ef­
fect of histamine and theophylline was due to their ability to raise in­
tracellular cyclic AMP concentrations, why wasn't the metabolism increased 
independently of secretion? This independence of the metabolic response 
was observed when exogenous cyclic AMP stimulated secretion.
As early as 1944, Roth and Ivy (l944) demonstrated that caffeine 
was a potent stimulant of gastric secretion in the caL and in man. Caf­
feine also potentiated histamine-stimulated acid secretion (Roth and Ivy,
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1944a). Years later it was demonstrated that caffeine and theophylline 
failed to stimulate gastric acid secretion in dogs, although these agents 
potentiated the effects of histamine (Robertson and Ivy, 1949). These 
findings were also reported by other investigators (Roth and Ivy, 1944; 
Merendino et al., 1945; Robertson et li., 1950). However, theophylline 
was found to initiate secretion of acid gastric juice in man either by 
oral or intravenous administration (Krasnow and Grossman, 1949).
These in vivo results were obtained before cyclic AMP was dis­
covered. With our present knowledge about cyclic AMP, the vivo ef­
fects of these methylxanthines on acid secretion seemed to fit nicely 
with the cyclic AMP hypothesis of gastric acid secretion, excepting only 
the action of these methylxanthines on gastric acid secretion in the dog.
Another approach to the problem was employed by Levine and his 
collaborators (1967). They studied the effects of acute and continuous 
intravenous infusion of cyclic AMP on histamine stimulated gastric acid 
secretion in conscious dogs with gastric pouches and in man. Unexpect­
edly in both species, the volume responses of secretion to histamine 
were depressed by cyclic AMP to one-third of the original values. Gas­
tric mucosal blood flow was concomitantly decreased as measured by amino- 
pyrine clearance in the dog. Two alternative mechanisms may account for 
the action of cyclic AMP on acid secretion in conscious dogs and man. 
Since gastric mucosal blood flow was decreased along with the decline in 
secretion, cyclic AMP may constrict blood vessels primarily, thereby de­
priving the gastric mucosa of its energy supply and secondarily reducing 
energy-dependent transport of ions. This possibility was supported by 
the fact that acid secretion and blood flow were not specifically affected
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by cyclic AMP, i.e., other adenine nucleotides (including 2',3'-AMP and 
5'-AMP), in comparable doses to cyclic AMP, were found to produce similar 
effects (Levine et al.., 1967). The other mechanism may be direct inhibi­
tion by cyclic AMP on the parietal cell secretory machinery. Since mu­
cosal blood flow has been shown to correspond directionally to changes 
in acid secretion (Jacobson et al.., 1966; Jacobson et al^. j 1967), the 
change in mucosal blood flow observed with infusion of cyclic AMP may be 
secondary to the decrease in acid secretion. Based upon the information 
from Levine et al.'s study, it is not possible to determine which explana­
tion is correct.
Cyclic AMP has been found to be poorly transportable through 
the plasma membranes of many tissues. It is not certain that the in­
fused cyclic AMP in Levine et al.'s experiment could pass through the pa­
rietal cell membrane and produce an inhibitory effect in the cell. Fur­
thermore, cyclic AMP is a nonspecific initiator of many physiological 
processes in an jji vivo system (Levine and Vogel, 1966; Levine et al..
1968). It would also be possible that the infused cyclic AMP triggered 
the release of some other humoral factors which were responsible for the 
inhibition of acid secretion.
Recently, Perrier and Laster (l970) measured mucosal adenyl 
cyclase activities. They found that in vitro histamine at 10“  ^M con­
sistently stimulated gastric mucosal adenyl cyclase of guinea pig stom­
ach, whereas choline esters and gastrin had no effect. These findings 
do not support the cyclic AMP hypothesis for gastric acid secretion, 
since gastrin and choline esters, as well as histamine, are potent secre- 
tagogues. If cyclic AMP is a final common mediator for acid secretion.
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adenyl cyclase in parietal cells ought to respond to all secretory stim­
ulants.
Studies of the relationship between prostaglandins and gastric 
acid secretion have yielded evidence both in favor of and against the 
role of cyclic AMP in secretory function of the stomach. Prostaglandins 
are a group of highly active, lipid soluble unsaturated hydroxy acids 
present in most if not all mammalian tissues. They have been found to 
have a wide spectrum of biological actions. The physiological roles of 
prostaglandins remain to be established.
It has been shown that prostaglandins inhibit several hormonal 
effects such as the effect of vasopressin on the toad bladder (Orloff 
et , 1965) and rabbit kidney tubules (Orloff and Grantham, 1967), and 
the effect of epinephrine on adipose tissue (Butcher and Baird, 1968). 
These antagonistic actions were associated with a decrease in the intra­
cellular accumulation of cyclic AMP. The effect of prostaglandins on 
gastric secretion has been studied in the amphibian (Way and Durbin, 
1969), the rat (Shaw and Ranwell, 1968; Main, 1969), the dog (Robert 
^  aJ., 1968, Jacobson, 1970) and in man (Horton et , 1968; Wilson 
ei^., in press). In all cases except one in man (Horton et ^ . , 1968), 
prostaglandins produced profound inhibition of gastric acid secretion 
stimulated by various means. The mechanism by which prostaglandins in­
hibit acid secretion is largely unknown. A direct inhibitory effect on 
the acid secretory cell has been suggested (Way and Durbin, 1969; 
Jacobson, 1970). More specifically, adenyl cyclase has been considered 
as a possible cellular site for the action of prostaglandins. In other 
words, prostaglandins may inhibit the secretory process by reducing
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cyclic AMP formation because the secretory effect of exogenous cyclic 
AMP on isolated frog mucosa was not reduced by the prostaglandins (Way 
and Durbin, 1969). However, in rat stomach prostaglandin did inhibit 
acid secretion in response to added cyclic AMP (Ramwell and Shaw, 1968). 
Thus, prostaglandins may also interfere with the cyclic AMP action in 
the cell.
Surprisingly, Perrier and Laster reported (l970) that prostag­
landins activated adenyl cyclase in guinea pig gastric mucosa. This 
seems to argue against the contention that acid inhibition by prostag­
landins involved cyclic AMP. It should be noted that this report by 
Perrier and Laster was in preliminary form. Furthermore, since gastric 
mucosa is nonhomogeneous, the stimulatory effect of the prostaglandins 
might be occurring in a cell type other than the parietal cells, a situ­
ation resembling that in adipose tissue (Butcher and Baird, 1968). A 
test of this possibility would not be possible until an isolated parietal 
cell preparation could be developed.
Aims of the Investigation
A logical division of molecular events in gastric secretion in­
volves three sequential steps which may not be independent of one an­
other: (i) activation of the acid producing system, i.e., the effects
of ser.retagogues on the parietal cells; (2) generation of hydrogen ions 
and chloride ions for formation of acid; and (s) active transport of the 
ions across the cellular membrane.
It appears reasonable to divide the gastric secretion process 
into the three steps cited above, although the initial activating step 
is hardly understood.
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There has been practically no effort directed toward bridging 
the gap between extracellular controls of parietal cell function and the 
intracellular secretory mechanism.
Recently, the historical discovery of cyclic AMP has turned a 
new page in the development of endocrinology. A number of hormones have 
been shown to stimulate the functions of their target tissues indirectly 
via activation of adenyl cyclase to produce cyclic AMP. The increase in 
intracellular cyclic AMP in turn promotes the expected cellular response. 
Thus cyclic AMP functions as a transmitter of the hormonal message from 
the outside to the inside of the cells.
Naturally occurring neurohumoral substances which provoke gas­
tric secretion, such as acetylcholine, gastrin and histamine are either 
charged compounds or polypeptide with a sizable molecular weight. They 
may not be able to penetrate the plasma membrane of the parietal cells 
and stimulate secretion of HCl within the cell. An alternative mechanism 
not requiring penetration of chemical stimuli through the parietal cell 
membrane would be their triggering a chain reaction which started on the 
extracellular side of the membrane; the best candidate for initial mem­
brane receptor for secretagogues would be the adenyl cyclase system. 
Harris and his collaborators were the first group of investigators to 
test this hypothesis. Their findings have evoked great interest, be­
cause of the potential value of their hypothesis in explaining the meta­
bolism of acid secretion by the stomach. Our comprehension of gastric 
acid secretion would be greatly advanced were cyclic AMP established as 
the final common mediator of gastric acid secretion, and adenyl cyclase 
shown to be the cell membrane receptor which transduces the message from
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extracellular secretagogues.
The conclusions of Harris and his collaborators (Harris et al..
1969) depend almost entirely upon their experiments, which focused upon 
the cyclic AMP degrading system, namely examining the effects of phospho­
diesterase inhibitors on acid secretion and cyclic AMP concentration in 
the frog gastric mucosa. They did not study actual enzymatic levels re­
sponsible for tissue cyclic AMP content with acid secretagogues or phos­
phodiesterase inhibitors. However, the effect of secretagogues on adenyl 
cyclase and phosphodiesterase must be regarded as one of the crucial 
points in testing the present hypothesis.
Recently, Perrier and Laster (l970) reported that histamine, a 
secretory stimulant, and prostaglandin E^ , a secretory inhibitor, both 
stimulated gastric mucosal adenyl cyclase activity of guinea pig with 
similar potencies, whereas choline esters and gastrin (secretory stimu­
lants) were without effect on the enzyme. Unfortunately, their abstract 
presented no data. At present, therefore, before the hypothesis of 
Harris and his coworkers can be accepted, a systematic study of the hy­
pothesis is apparently needed.
The research of this dissertation was designed primarily to fo­
cus on measurements of acid secretory rates and the activities of adenyl 
cyclase and phosphodiesterase in canine gastric mucosa. In addition, 
the effect of exogenous cyclic AMP on gastric acid secretion was deter­
mined, employing intra-arterial infusions of dibutyryl cyclic AMP to max­
imize penetration of the nucleotide into the parietal cells (Posternak 
et al., 1962).
By using above approaches the present investigation was ad-
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dressed to answering five questions: (l) Can substances which inhibit
gastric phosphodiesterase activity in vitro stimulate acid secretion 
when injected into intact animals intravenously or intra-arterially?
(2) Are there parallel changes in phosphodiesterase activity and acid 
secretory rate during the administration of phosphodiesterase inhibitor?
(3) Does the classical acid secretagogue, histamine, affect gastric mu­
cosal adenyl cyclase activity Jji vitro? (4) Does intravenous infusion 
of histamine yield directional changes in gastric adenyl cyclase activ­
ities and acid secretory rates? and (s) Can dibutyryl cyclic AMP initi­
ate acid secretion in intact animals when given by intraarterial infus­
ion?
CHAPTER II 
METHODS AND MATERIALS
In order to meet the objectives set for this investigation, 
three major experimental approaches were designed; (l) the effect of 
theophylline and papaverine on gastric phosphodiesterase activity in 
vitro and in vivo, as well as the acid secretory response of the stomach 
to these drugs; (2) the effect of histamine on adenyl cyclase activity 
in vitro and the relationship between acid secretion and adenyl cyclase 
activity during the in vivo administration of the secretagogue: and (s) 
the acid secretory response to increased concentrations of cyclic AMP in 
gastric cells induced by intraarterial infusion of dibutyryl cyclic Af/.P.
Animal Preparation
Mongrel dogs of either sex weighing from 15-20 kg were used.
Food was withdrawn for 24 hours before use. Each dog was anesthetized 
with an intravenous injection of chloralose (55 mg/kg dissolved in a so­
lution containing 0.5 gm of ethyl carbamate per ml of saline). The dog 
was maintained in a supine position under anesthesia. A femoral artery 
and vein were cannulated, the former connected with a Sanborn pressure 
transducer for monitoring the blood pressure during the experiment and 
the latter for drug infusion and supplemental anesthestic.
A midline abdominal incision was made with an electrical cautery
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device. A wedge of stomach wall was exclced from the greater curvature 
in the region of the gastroepiploic vessels, but its blood supply was 
maintained intact (Fig. l). The wedge was brought out of the peritoneal 
cavity and secured between a Lucite ring and a partitioned chamber. The 
mucosal surface of the stomach flap was enclosed and divided by the cham­
ber into two equal halves, each with its own blood supply. On the top 
of the chamber, there was one large window for each half of the stomach 
flap, designed to allow the obtaining of biopsies of mucosa. One outlet 
from each half of the chamber permitted collection of gastric juice 
(Fig. l). The chamber was fixed in a position slightly above the ante­
rior peritoneal wall for the duration of each experiment.
For experiments with intraarterial infusion, a branch of the 
splenic artery leading to the spleen was cannulated so that the infusate 
could be administered in the direction of the stomach tissue. The exper­
iments were begun about 30 min after finishing all surgical procedures.
Chemical Assavs
Assay of Cyclic Nucleotide Phospho­
diesterase Activity
The assay was performed in three separated steps: enzymatic
reactions, inorganic phosphate determination and protein determination.
Principles of the assav.
Enzymatic reactions. The reaction system was modified from the 
method of Butcher and Sutherland (l962), which included two enzymic reac­
tions taking place in a single incubation mixture. The mixture was com­
posed of cyclic AMP, an excess of snake venom containing a potent 5'- 
nucleotidase and Tris buffer with Mg"^ ions. When the tissue preparation
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Figure 1. Chambered segment preparation of the dog stomach.
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containing the phosphodiesterase activity to be assayed was added into 
the reaction mixture, it cleaved the 3'-ester bond of cyclic AMP to pro­
duce 5'-AMP. In the presence of b'-nucleotidase, the 5'-AMP formed in 
the phosphodiesterase reaction was immediately converted to adenosine and 
inorganic phosphate. The cyclic AMP concentration in the reaction mix­
ture was chosen to reveal the full activity of phosphodiesterase. The 
quantity of snake venom used assured a complete conversion of formed 5'- 
AMP to adenosine and phosphate. Thus the increase in phosphate concen­
tration in the mixture in the presence of a given amount of tissue re­
flected the enzymic activity of phosphodiesterase.
Inorganic phosphate determination. The determination was done 
according to a method described by Buell et _al. (l958). The principle 
involved was based upon the fact that phosphomolybdic acid is easily re­
duced to yield a highly colored compound which can be measured colori- 
metrically. A phosphate reagent containing ammonium molybdate and ascor­
bic acid in sulfuric acid was used. In the solution, molybdic acid was 
formed through the reaction of ammonium molybdate and sulfuric acid.
%en standard ^ 2 ^ 4  samples containing an unknown quantity of inor­
ganic phosphate was added to the reagent, the inorganic phosphate reacted 
with molybdic acid to form phosphomolybdic acid. This complex acid was 
readily reduced by the reducing agent, ascorbic acid. The intensity of 
the blue color displayed by reduced complex acid was linearly proportional 
to a wide range of the concentrations of inorganic phosphate existing in 
the mixture.
Protein determination. The principle was similar to the one 
for the inorganic phosphate determination described previously. The
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solution, Folin's phenol reagent, contained mainly phosphomolybdic and 
phosphotungstic acids. Both complex acids could be reduced in alkaline 
condition by phenol or oxybenzol compounds to form color substances, 
which resemble the corresponding unreduced compounds in all respects, ex­
cept that of color. Taking advantage of this fact, Wu (l922) first pro­
posed to determine protein concentration by using the Folin phenol rea­
gent, for proteins generally contain aromatic amino acids such as tyro­
sine and tryptophan, which can reduce phosphomolybdictungstic acids to 
form color products. The blue color obtained is not stable in strong 
alkaline condition. It was found that the best alkali for the purpose 
was sodium carbonate (Folin and Denis, 1912). Lowry et a^ . (l95l) sub­
sequently modified Wu's method by pretreating the proteins with alkaline 
copper solution prior to the reaction with phenol reagent. They found 
that copper treatment of protein was advantageous not only because in the 
presence of copper alkaline treatment resulted in a 3- to 15-fold increase 
in color and acceleration of color development at room temperature, but 
also because copper minimizes the differences in extinction coefficients 
originated in the reactions of different proteins with the Folin reagent. 
The origins of the copper effects are unknown.
Working solutions and reagents.
1) Tris-Mg buffer, pH 8.3: The buffer was made by placing
6.055 gm of Tris (TrisLhydroxymethylJaminomethane) and 739.5 mg of 
MgSO^‘7 H2O in a 1-liter graduated beaker and filling with approximately 
900 ml of deionized water. A magnetic stirrer was used to accelerate the 
dissolution and mixing. The pH of the solution was measured with a glass 
electrode on a Sargent-Welch pH meter. After the solids were completely
45
dissolved, the pH was titrated to 8.3 with 10.2 N HCl. The solution was 
then poured into a 1-liter graduated cylinder and was filled to exactly 
1 liter with water. The final solution contained 50 mM Tris and 3 mM 
MgSO^.? H2O. The pH of the solution was once again checked when the mag­
netic stirrer was in use. The solution was stored in the refrigerator.
2) Cyclic AMP solution, 2.5 mM: 32.92 mg cyclic MfP disodium
salt were weighed out on a Mettler semi-micro balance and dissolved in 
40 ml of Tris-Mg buffer. The solution was stored in a freezer. New 
solution was made for every month.
3) Snake venom, 1 mg/ml: The solution was made fresh each time 
it was used, by dissolving a sufficient amount of snake venom powder in 
Tris-Mg"*^  buffer to make a concentration of 1 mg/ml.
4) Theophylline solutions: 0.1753 gm of aminophylline was dis­
solved in 20 ml of Tris-Mg bufferto form a theophylline stock solution 
with a concentration of 41.7 mM. A series of five 20-ml test tubes, each 
with 5 ml Tris-Mg buffer were prepared, 5 ml of the theophylline stock 
solution were transferred to the first of the serial tubes. After the 
solution in the first tube was well mixed, 5 ml of it was pipetted into 
the second tube. The same procedure was repeated until serial concen­
trations were made, each concentration being 50^ diluted as compared to 
the previous one. The concentrations of these 6 solutions were: 41.7,
20.8, 10.4, 5.2, 2.6 and 1.3 mM, respectively. They were stored in a 
freezer until they were used.
5) Papaverine HCl solutions: 0.1879 gm of papaverine HCl was
dissolved in 20 ml of warm deionized water to form a papaverine HCl solu­
tion of 25 mM. The rest of the procedure was the same as that used in
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preparing theophylline solutions, except that warm deionized water al­
ways replaced Tris-Mg buffer for papaverine, because papaverine HCl is 
readily precipitated in an alkaline pH. The concentrations of the papa­
verine solution 'were 25, 12.5, 6.25, 3.13, 1.56 and 0.78 mM, respectively. 
They were stored in the freezer.
6) Standard phosphate solutions: A graded series of concentra­
tions of the standards were made by dissolving 65.3 mg of KH2PO4 200 
ml of Tris-Mg"^ buffer and diluting to the appropriate concentrations 
with the buffer in the manner described above. These standard solutions 
were kept in a refrigerator for long time periods without an appreciable 
change developing in the standard phosphate curve.
7) Trichloroacetic acid (TCA), 2.5^ (w/w): 2.5 gm TCA was dis­
solved in 97.5 ml deionized water.
B) Trichloroacetic acid (TCA), 55% (w/w): 110 gm TCA was added
to 90 ml deionized water. The solution was stored in a glass bottle.
9) Sulfuric acid, 0.2 N: 10 ml of 36 N H2SO4 was diluted to 
1800 ml by adding acid into deionized water.
10) Phosphate reagent: The reagent was prepared freshly for each
experiment by dissolving a sufficient amount of ammonium molybdate and 
ascorbic acid in 0.2 N H^SO^ to achieve a concentration of 0.1% for the 
former and 3% for the latter. The glassware used for this reagent was 
washed thoroughly with acid before use. The color of the reagent was a 
transparent light yellow.
11) Cupric EDTA reagent: 250 mg of EDTA ([Ethylenedinitrilo] 
tetraacetic acid), disodium cupric salt was dissolved in 200 ml of de­
ionized water. Simultaneously, 500 ml of deionized water was added to
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another beaker with 20 gm of sodium carbonate powder and 4 gm of sodium 
hydroxide pellets. After the constituents of the two solutions were com­
pletely dissolved, the two solutions were mixed in a 1-liter volumetric 
flask and filled to the mark with additional water. The reagent was 
stored at room temperature.
12) Phenol reagent, 1 N: Commercial 2 N solution was diluted
one-fold with deionized water and stored at room temperature.
13) Bovine serum albumin, 1 mg/ml : 10 mg of bovine serum al­
bumin powder were dissolved in 10 ml of Tris-Mg buffer by gently ro­
tating the bottle. The solution was stored frozen.
Working procedures.
A. Treatment of tissue samples. For jjn vitro study, a suffi­
cient amount of canine mucosa was pealed off from the fundic area of the 
dog stomach. The mucosal tissue was immediately immersed into a beaker 
of ice cold distilled water. This procedure not only provided quick 
cooling of the tissue, but also washed off the residual blood which ad­
hered to the tissue. The washed tissue was subsequently blotted with a 
piece of gauze sponge. The residual submucosal tissue was carefully 
trimmed away with a pair of fine scissors. The mucosal tissue was then 
frozen in liquid nitrogen. After completely freezing, the tissue was 
transferred and stored in the freezer until it was used.
In in. vivo experiments, biopsy samples of mucosa were taken from 
one half of the chambered segment with a biopsy instrument at definite 
time intervals. The rest of the treatment was the same as for the tissue 
in the in vitro study.
Enzymatic preparation of phosphodiesterase was made by grinding
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the mucosal tissue in Tris-Mg'*"*’ buffer with a polytron for 1 min. In 
order to have a complete broken cell preparation, the tissue solution 
was further homogenized in a Kontes Duall glass homogenizer for about 
1 min. The final concentration of the preparation was approximately 80 
to 100 mg wet weight of the tissue per ml.
B. Enzymatic reactions. Enzymatic incubation took place in 
small culture tube sized 10x75 mm. For each experiment, a batch of cul­
ture tubes were prepared and divided into two groups: a) Sample group:
In this group, each tube contained 100 microliter (pi) of snake venom,
200 pi of enzyme preparation and 300 pi of Tris-Mg'*’*’ buffer or the same 
volume of the various concentrations of testing substances. Every two 
tubes had exactly the same content, b) Standard phosphate group: 400 pi
of each standard KH2PO4 solution was pipetted into a tube containing 
100 pi of Tris-Mg’*’^ buffer and 100 pi of snake venom. No tissue was 
added.
All tubes were then warmed up in a water bath at 37°C for 5 min. 
For starting the reaction, in the sample group, 400 pi of cyclic AMP so­
lution were pipetted into one of every two tubes with the same content.
The other tube received 400 pi of Tris-Mg buffer to serve as the inter­
nal control. All tubes in the standard group recieved 400 pi of Tris-Mg’*'* 
buffer. After adding the final constituent, the content of the tubes was 
mixed by a vortex shaker. The total incubation volume in each tube was 
1 ml. All tubes were allowed to incubate at 37°C for 30 min before the 
reactions were arrested by adding 200 pi of 55% TCA.
For assaying the phosphodiesterase activity from biopsy samples, 
exactly the same procedures were carried out, but no exogenous testing
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substances was used.
C. Inorganic phosphate determination. The denatured proteins 
in the reaction mixture were precipitated by centrifuging at 3, COO x g 
in an International centrifuge (Boston, Mass.) for 15 min. 0.5 ml of 
supernatant from each tube was transferred to another set of culture 
tubes. 0.5 ml of 2.5% TCA served as a blank. The color reaction was in­
itiated by adding 1.5 ml of phosphate reagent, mixing and incubating for 
20 min at 37*0. Optical densities (OD) were measured at 700 mp in a 
spectrophotometer (Gilford Co., Oberlin, Ohio) against the TCA blank.
The OD readings from 6 graded phosphate standards formed a calibration 
curve when plotted against standard phosphate concentrations on a linear 
scale.
D. Protein determination. The chemical procedure for protein 
determination was undertaken according to a modified method originally 
reported by Lowry et (l95l). Both albumin standards and the samples 
were diluted to 1 ml in a serial 10-ml test tubes. 5 ml of cupric EDTA 
reagent were added to each tube. The contents of the tubes were mixed 
and incubated for approximately 30 min at room temperature. 0.5 ml of
1 N phenol reagent was subsequently pipetted into each tube with immedi­
ate mixing. All tubes were allowed to stand at room temperature for ex­
actly 30 min. Their CD's were then read at 700 mp in the spectrophoto­
meter against a water blank. A calibration curve was constructed by 
plotting the OD readings from 6 graded protein standards on a linear 
scale against the concentrations of the standards.
E. Methods of calculations. In the phosphate determination, 
the OD differences between the samples and their own internal controls
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represented the true OD derived from that produced by inorganic phosphate 
in the enzymatic reactions. Based upon the phosphate standard curve, the 
concentration of enzymatically produced phosphate was known. This cal­
culated phosphate concentration was multiplied by the total volume of 
1.2 ml (l ml of reaction mixture plus 0.2 ml of 55% TCA) to obtain the 
total inorganic phosphate produced by the action of phosphodiesterase.
The protein concentrations of the samples were calculated based upon the 
values taken from the protein standard curve. Therefore, the amount of 
protein used in each sample was known. The total inorganic phosphate 
produced was divided by the amount of tissue protein used in the reaction 
and by the incubation tissue (30 min) to obtain the specific activities 
of mucosal phosphodiesterase in the samples. All calculations were done 
with a desk computer.
Assay of Adenyl Cyclase Activity
Principle of the assav.
Enzymatic reaction. The principle was based on the fact that 
exogenous ATP can be converted to cyclic AMP by tissue adenyl cyclase.
By using radioactive C^ '^ -ATP as the substrate, a minute quantity of cy­
clic AMP which has been converted frcxn ATP, can be detected by highly 
sensitive radioactive scintillation counting.
Purification of labeled cyclic AMP. In order to separate radio­
active cyclic AMP produced in the adenyl cyclase reaction from excess ATP 
and possible contamination from 5'-AMP, two steps of purification were 
carried out: column chromatography and Ba -Zn precipitation. Both 
steps took advantage of the characteristics of the cyclic structure, 
namely the single phosphate group in a cyclic AMP molecule which is
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esterized to the ribose moiety with two ester bonds, thereby leaving one 
ionized group on the phosphate. In contrast, both ATP and 5’-AMP have 
more ionizable groups in their molecules. When the supernatant of the 
enzymatic reaction mixture was placed on the top of a cation exchange 
column (AG-50,X8) and eluted with deionized water, ATP readily came out 
of the column in the first 2 ml fractions. The majority of cyclic AMP 
was recovered in the following 2 ml fractions; 5'-AMP (if any) began to 
show up in the 5th ml fraction.
Ba -Zn precipitation was first employed by Krishna to purify 
the cyclic AMP fraction. He found that barium hydroxide (Ba[0H]2) and 
zinc sulfate (ZnSO^), when combined in use, were able to precipitate quan­
titatively a variety of nucleotides except cyclic compounds (Krishna 
e t ^ . , 1968). Consequently, the combination of column chromatography 
and Ba''-Zn'' precipitation has proved to be a powerful method to purify 
cyclic AMP from ATP and other products formed during the incubation with 
crude adenyl cyclase preparation.
Working solutions and reagents.
1) Tris-Mg"^ buffer: The buffer was made by the procedure de­
scribed previously for the assay of phosphodiesterase, except that the 
pH was adjusted to 7.4.
2) Cyclic AMP solution, 0.6 x 10”^ M: 0.0395 gm of cyclic AMP
disodium salt were dissolved in 20 ml Tris-Mg buffer.
3) AG50-X8 resin suspension, 50^ (v/v): The commercial resin
(200-400 mesh) was washed in 0.2 N HCl. Deionized water subsequently re­
placed the acid and the washing procedure was repeated until the pH of 
the suspension became identical to that of deionized water. 50^ (v/v)
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suspension was finally made.
4) C^^-ATP solutions: C^ '^ -ATP powder obtained from New England
Nuclear Co. 250 pci with specific activity of 29.2 mci/mmole were packed 
in a small sealed bottle. Before C^ '^ -ATP was used, it was subjected to
I I
chromatographic purification. 0.5 ml of Tris-Mg buffer was used to 
dissolve the ATP powder in the bottle. The solution was placed on the 
AG50-X8 column (0.4 x 3 cm) prepared by pipetting 2 ml of resin suspen­
sion into a glass column of 22 cm in length, including a 35 ml reservoir. 
Another 0.5 ml of buffer which was used to wash the radioactive bottle 
was also pipetted into the column. The total 1 ml elution was collected. 
The column was further eluted with an additional 1 ml of buffer. This 
second fraction was collected and mixed with the first ml elution to form 
the purified C^^-ATP stock solution. 5 pi of it in 10 ml of aquasol 
(scintillation fluid) were counted in a liquid scintillation counter 
(Nuclear-Chicago Co.). By knowing the total counts of the stock solu­
tion and its specific activity (same as original commercial product), the 
concentration of the stock solution could be calculated.
Two 0^‘^-ATP working solutions: (a) C^ '^ -ATP solution #1 (0.5
pci/O.l pmole, 20 pci/ml) and (b) C^ '^ -ATP solution #2 (l pci/O.l pmole,
20 pci/ml) were prepared by diluting the stock solution with sufficient 
nonradioactive ATP and Tris-Mg"*~*" buffer. All 0^‘^-ATP solutions were 
stored in a deep freeze.
5) Zinc sulfate (ZnSO^), 8.0^ (w/v): 16 gm of zinc sulfate pow­
der were dissolved in deionized water to a final volume of 200 ml.
6) Barium hydroxide (Ba[0H]2), 7.2% w/v): deionized water was
added to a 200-ml volumetric flask containing 14.4 gm of barium hydroxide
53
crystals. The solution was vigorously stirred by a magnetic stirrer un­
til all crystals dissolved. Because barium hydroxide easily absorbs car­
bon dioxide to form an insoluble precipitate, the flask was tightly stop­
pered when not in use.
7) Histamine2HCl, 4 x 10”^ M: 73.6 mg of histamine2HCl powder
I I
was dissolved in 10 ml Tris-Mg buffer. Various concentrations of hist­
amine solutions were made by diluting this stock solution with the addi­
tion of Tris-Mg'*"*’ buffer.
S) Sodium fluoride (NaF), 4 x 10”  ^M: 33.6 mg of sodium fluo­
ride powder were added to 20 ml of Tris-Mg’*"*’ buffer.
9) Aquasol (scintillation fluid).
Working procedures.
A. Treatment of the tissue. The procedures carried out were 
similar to those for the phosphodiesterase assay, except that the con­
centration of tissue in the homogenate was approximately 150 mg of wet 
weight of tissue per ml of Tris-Mg buffer for canine enzymic prepara­
tion.
When guinea pig gastric adenyl cyclase was assayed, the mucosal 
surface of the stomach was washed sith ice cold water and blotted with 
filter paper. The mucosal tissue was scraped from outer muscularis mu­
cosa and immediately homogenized in cold Tris-Mg buffer of pH 7.4 with 
a Kontes Duall glass homogenizer. The final concentration of the guinea 
pig enzymic preparation was about 300 mg of wet weight of tissue per ml 
of buffer.
B. Enzymatic reaction. The reaction took place in a small cul­
ture tube (10 X 75 mm). 100 pi of incubation medium of Tris-Mg'*’*’ buffer
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(Tris, 50 X 10”^ M and %S0^, 3 x 10"^ M) contained: cyclic AMP
(lx5 X 10"3 M); C^^-ATP (either 1 mM or 0.5 mM) ; various concentrations 
of testing substances; and tissue (0.7 - 0.8 mg of dry weight). All sam­
ples were duplicated for each experiment. The incubation was allowed to 
continue for various amounts of time at 37"C before the reaction was ter­
minated by immersing the tubes in a boiling water bath for 5 min. All 
tubes were chilled in ice water and then centrifuged for 15 min at 
3,000 X g.
C. Purification of produced radioactive cyclic AMP. The super­
natant of the reaction mixture was chromatographed on AG50-X8 column pre­
pared as previously described. The column was eluted with deionized wa­
ter. The first 2 ml of elution contained almost lOC^ of C^ '^ -ATP put on 
the column and were collected for determination of ATP recovery. The 
following 2 ml of eluate contained 75 to 8C^ of the total amount of cy­
clic AMP in the reaction mixture. With the cyclic AMP fraction, a volume 
of 3 ml was reached by adding 1 ml of deionized water. 250 pi each of 
ZnSO^ and Ba(0H)2 solution were added and thoroughly mixed. Without in­
tervening centrifugation, the addition of ZnSO^ and Ba(0H)2 solution was 
repeated. The mixture was then centrifuged at 3,000 x g for 25 min.
D. Scintillation counting, optical density measurement and tis­
sue measurement. 2 ml of the supernatant of the precipitated solution 
were added to 15 ml of aquasol in a scintillation counting vial. The 
radioactivity was measured in the liquid scintillation counter. 0.5 ml 
of supernatant were used for checking the optical density (OD) in the 
spectrophotometer against a water blank at 260 mp. The recovery of cy­
clic AMP was computed by treating the OD of a standard as the lOC^  re-
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covery. The OD standard contained 4 ml of deionized water and the same 
amount of cyclic AMP as was used for the sample. For quantitative anal­
ysis, all adenyl cyclase activities were expressed in terms of the amount 
of labelled cyclic AMP produced per mg of dry weight of the tissue used 
in enzymatic reaction. The dry weight of the tissue was obtained by 
pipetting 25 pi (the same volume as used for enzymic reaction) of tissue 
homogenate into a small culture tube whose weight had been recorded and 
by drying the tissue in a vacuum dessicator for two days. The weight of 
the combination (dry tissue plus tube) was subtracted by the weight of 
the empty tube to obtain the weight of dry tissue.
E. Method of calculations. The calculations of the data were 
performed using the desk computer which had been programmed with the fol­
lowing formula:
A.C.A. . ^  (cpm-BC) • ^  ^  ^  ^
A.C.A. : Adenyl cyclase activity in terms of pico moles of
cyclic AMP produced per my of dry weight of tissue.
Ty: Total volume (ml) of supernatant after Ba^-Zn"*^
precipitation.
Vç.: Volume for scintillation counting, i.e., 2 ml.
cpm: Counts per minute of 2 ml of supernatant.
BC: Background counts (cpm) of the cyclic AMP fraction
from a sample without addition of tissue.
Rq: Recovery of cyclic AMP calculated from optical density.
E^: Efficiency of the scintillation counter.
Fdpm' A conversion factor of 2.22 x 10^ which converts dpm
(disintegration per min) to pci (microcuri).
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SA: Specific activity of C^ '^ -ATP used in terms of pci
per pmole.
Dry weight (mg) of the tissue used in the reaction.
Experimental Designs
In Vitro Study of Phosphodiesterase Inhibitors
For each experiment, 3 groups of the culture tubes were prepared 
as follows: a) Theophylline group. In this group, each tube contained
300 pi of a theophylline solution, 100 pi of snake venom and 200 pi of 
enzymic preparations; b) Papaverine group. Each tube contained 50 pi of 
a papaverine solution and 250 pi of Tris-Mg buffer. The other consti­
tuents were the same as in the theophylline group; c) Standard phosphate 
group. The standards were set up as described previously.
The rest of the chemical procedures for all 3 groups were car­
ried out according to the method stated in the section of Chemical Assav.
In Vivo Study of Phosphodiesterase Inhibition 
and Acid Secretion
Intravenous administration of phosphodiesterase inhibitors. The 
solutions of theophylline and papaverine HCl were prepared freshly for 
each experiment. Theophylline solution was made by dissolving a suffi­
cient amount of aminophylline powder in 10 ml of saline to provide a dose 
of 0.016 gm of theophylline per kg of body weight. Papaverine solution 
was prepared similarly to provide a dose of 6 mg per kg.
The experiments were begun with a one-hour control period, with­
out using any treatments on the dog other than monitoring the blood pres­
sure. During the experiment, at the end of every 30 min, one biopsy was
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taken and secretion (if any) was drained by gravity. The volume of se­
cretion was measured and recorded. The concentration of acid in the se­
cretion was subsequently determined with an automatic titrator (Radio­
meter, Copenhagen, Denmark) to a pH of 7.0. Acid output was calculated 
from the volume and the acid concentration of the secretion. Either 
theophylline or papaverine solution was injected at the end of the con­
trol period into the femoral vein as a bolus. Biopsies were taken at 5, 
15, 30 min, and 1 hr following the injection. Intravenous infusion of 
histamine in a dose of 30 p,g/kg-hr was started immediately after taking 
1-hr biopsy by using a constant flow infusion pump (Harvard Apparatus 
Co., Dover, Mass.). During the l-l/2-hr histamine infusion period, 4 
additional biopsies were obtained at 15, 30, 60 and 90 min following the 
start of infusion. Blood pressure changes were closely monitored through­
out the experiment, since histamine, theophylline and papaverine are de­
pressor drugs. The quantities of these substances to be used were largely 
limited by their hypotensive effects, especially when theophylline or 
papaverine was used in combination with histamine. The dose of 0.016 gm 
of theophylline per kg caused a 10 to 15% decrease in blood pressure be­
fore the infusion of histamine began, and a 20 to 30% decrease by the end 
of the histamine infusion period. Papaverine in a dose of 6 mg/kg has 
somewhat less effect on arterial blood pressure.
Intraarterial administration of phosphodiesterase inhibitors.
In order to minimize the effect on blood pressure and to increase the 
local concentration in the mucosal tissue, either theophylline or papav­
erine was infused into the gastroepiploic arteries. . For each experiment, 
either 3 doses of theophylline (0.2, 0.4 and 0.8 mg/kg-min) or 2 doses of
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papaverine (0.15 and 0.3 mg/kg-min) were employed. Increase in dosage 
was effected by increasing the infusion rate of the pump. Each dose of 
the inhibitor was continued for 20 min. After termination of inhibitor 
infusion, no histamine was given. One biopsy sample was obtained at the 
end of every 20-min period. The remainder of the procedures were the 
same as those in the previous set of experiments.
The effect of both inhibitors in the highest doses on arterial 
blood pressure was similar to the effect with intravenous (l.V.) injec­
tion, since the total quantity of each drug used in intraarterial (I.A.) 
infusion was considerably greater than in l.V. injection.
In Vitro Study of Adenyl Cyclase Activity 
Gastric adenyl cyclase activities in vitro were examined in 
both canine and guinea pig mucosal tissues. Two types of experiments 
were done with canine enzymic preparation: (l) Adenyl cyclase activities
were assayed in the presence of various concentrations of histamine with 
different incubation times. Either solution #1 (0.5 pci/O.l pmole) or 
solution #2 (l pLCi/O.l pmole) of C^^-ATP was used in the assay system.
The effect of NaF on the enzyme was also examined in every experiment.
The response of the enzyme to NaF was taken as an indication that enzy­
mic preparation was sound. (2) Another type of experiments was dealing 
with the combined effect of histamine and NaF on gastric adenyl cyclase. 
The amount of NaF used in the combination was known to produce a submax- 
imal stimulation by itself. The enzymic activities assayed in the pres­
ence of both histamine and NaF were compared to those obtained with the 
same amount of NaF alone.
With guinea pig mucosal tissue, only the first type of design
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was performed. NaF was used for the same purpose.
In Vivo Study of Histamine Effect on Adenyl 
Cyclase Activity and Acid Secretion
Two periods were included in each experiment. Following the 
first hour control period, histamine was infused intravenously at a dose 
of 30 pg/kg-hr for two hours. One tissue biopsy was taken at the end of 
the control period and two others at 90 min and at 2 hr following the 
beginning of the histamine infusion. At the end of every 30 min period, 
blood pressure and secretory volume were recorded. The acid concentra­
tion of the secretion was determined as stated above.
In Vivo Study with Dibutyryl Cyclic AMP 
Experiments were designed to include 3 sequential hour-long 
periods. After the first hour of control an intraarterial infusion of 
dibutyryl cyclic AMP was initiated. Two doses of dibutyryl cyclic AMP 
were used, 0.1 mg/kg-min for the first 30 min and 0.2 mg/kg-min for the 
second half hour. After this a 1-hour control period with intraarterial 
saline infusion followed. Blood flow to the stomach flap was measured 
every 30 min in two control periods and every 15 min during the infusion 
of dibutyryl cyclic AMP. An electromagnetic blood flow transducer 
(Micron, Los Angeles, Calif.) of either 2.0 mm or 1.0 mm size was used 
on the blood vessel for measurement of flow. The flow probe was connected 
to a 610 pulse logic flowmeter amplifier (Biotronex Laboratory, Inc., 
Silver Spring, f<U.). The transducer had been previously calibrated in 
vitro with whole blood. The zero flow determination was obtained by oc­
cluding the vessel with a hemostat at a locus immediately distal to tne 
probe. Blood flow values were then determined by measuring the distance
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between the undisturbed mean flow and the subsequent zero on the graphic 
recording and measuring this deflection with the calibration for the flow 
probe. Beside the blood flow measurements, arterial blood pressure and 
secretory rates were determined as previously described, except that the 
blood pressure was measured every 15 min during the dibutyryl cyclic AMP 
infusion.
Method of Statistical Analvsis 
Since the majority of the experimental results in this investi­
gation were considered based upon comparisons among the treatments and 
the controls, Duncan's new multiple-range test was, therefore, employed 
to examine the pair-wise comparisons of the means. The experiments were 
regarded as completely random in design (Steel and Torrie, I960). The 
5% level of significance was chosen for analysis. The missing data were 
approximated by the usual missing data formula for randomized complete 
block analysis. The actual calculations were performed on an IBM 1800 
data acquisition and control computer system.
CHAPTER III 
EXPERIMENTAL RESULTS
In Vitro Effect of Theophylline on Gastric 
Mucosal Phosphodiesterase Activity
Phosphodiesterase was prepared with mucosal tissue taken from 6 
different dogs. Each preparation was assayed with and without theophyl­
line. The final concentrations of the inhibitor in the reaction mixtures 
were 0.39, 0.78, 1.56, 3.13, 6.25 and 12.5 mM. Phosphodiesterase activ­
ities under the influence of theophylline were expressed as the percent­
age change from the controls (without theophylline) by regarding the ac­
tivities of the controls as 10C%. The results are shown in Fig. 2. Mean 
values + standard errors of percentage inhibition of phosphodiesterase 
activities from 6 enzymic preparations were plotted against the final 
concentrations of the inhibitor. A hyperbolic curve describes the rela­
tionship. The inhibitory effect of theophylline was greatly enhanced 
(from 0 to about 3C%) when concentration of the drug was increased from 
0 to 1.56 mM. Further increase in drug concentration up to 12.5 mM pro­
duced much smaller increments in inhibitory effect. For the statistical 
analysis, actual enzymic activities were used instead of the percentage 
inhibition. It was found that each doubling of the drug concentration 
caused a significant decrease in enzymic activity, except the doubling 
between 3.13 and 6.25 mM. These results demonstrated that theophylline
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is an inhibitor of phosphodiesterase activity in the gastric mucosa of 
the dog.
In Vitro Effect of Papaverine on Gastric 
Phosphodiesterase Activity
A study similar to the preceding one was conducted with a dif­
ferent enzymic inhibitor, papaverine. The results of 6 experiments are 
presented in Fig. 3. A hyperbolic curve was also obtained with papaver­
ine when a plot was made of the percentage inhibition of phosphodiester­
ase activity as a function of the concentration of papaverine in the as­
say system. The molar concentrations of papaverine used were l/lO the 
molar concentrations of theophylline employed in the preceding experi­
ments. However, the dose response curve for papaverine showed a steeper 
slope than the plot for theophylline. A 5C^ inhibition was found with a 
concentration of papaverine less than 0.313 mM. 1.25 mM papaverine pro­
duced a 9C^ inhibition of the enzyme. These observations indicate that 
papaverine is about 20-fold more potent than theophylline as an inhibitor 
of gastric mucosal phosphodiesterase in vitro. Statistical analysis of 
the differences in inhibition with various concentrations of papaverine 
was performed using the actual phosphodiesterase activities. It was 
found that the mean enzymic activities with the concentrations of papa­
verine ranging from 0 to 1.25 mM were significantly different from one 
another except at the two lowest concentrations of the inhibitor (0.039 
and 0.078 mM).
Acid Secretory Response of the Canine Stomach to the 
Intravenous Administration of Phospho­
diesterase Inhibitors
Thirteen dogs were used in these experiments: 6 dogs served as
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control animals; 5 dogs were used to test theophylline, and 2 dogs were 
used to test papaverine. All animals were prepared with a chambered seg­
ment of the stomach (Fig. l). Observations of acid secretion in both 
control experiments and in experiments with theophylline have been sum­
marized in Figure 4. There was no spontaneous gastric secretion in any 
of the animals. Following two 1-hour control periods, the control ani­
mals were administered histamine by intravenous infusion at a dose of 
30 jig/kg-hr. This treatment evoked a secretory response. The mean acid 
output from 6 dogs increased to 0.29 mEq/so min by the end of the first 
hour after the onset of histamine infusion and to 0.38 mEq/30 min at 90 
min.
In the 5 dogs used to test theophylline, a dose of this drug 
(0.016 g/kg) was injected intravenously. In none of these animals did 
gastric secretion increase from basal levels over the next hour. How­
ever, acid secretory rates did increase in response to the subsequent 
infusion of histamine and these rates were significantly higher than 
those observed in the control animals (histamine alone), at least at 60 
min and 90 min following the infusion of histamine. The mean acid out­
put measured at these two collection periods were 0.8 and 0.9 mEq/30 min, 
respectively. These results indicate that theophylline does not initiate 
gastric secretion in the resting stomach of the dog, although it poten­
tiates the response to histamine.
Figure 5 shows a comparison of acid secretory response between 
control animals and 2 animals treated with papaverine (0.6 mg/kg). No 
acid secretion was observed after the intravenous administration of pa­
paverine for 1 hour. The average acid output from 2 experiments in which
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both histamine and papaverine were given appeared greater than the out­
put from control dogs in which histamine alone was administered. The 
number of experiments was too small for a meaningful statistical analy­
sis, although these results support the preceding findings with theophyl­
line.
Control Studv of Gastric Phosphodiesterase in Vivo
Mucosal biopsies were taken at various times from the control 
group of animals in the preceding experiments. Tissues were assayed for 
phosphodiesterase activity. Table 1 shows all specific activities of the 
enzyme in the 6 control dogs. No significant differences were found 
among the 5 mean values (enzyme activity vs time) shown in the table. 
These results indicate that phosphodiesterase activity in the animals 
without treatment was not influenced by a time factor.
Gastric Phosphodiesterase Activitv in Response 
to Intravenous Administration of 
Theophylline and Papaverine
Tissue phosphodiesterase was prepared from the biopsies obtained 
at various times in the animals treated with 0.016 gm/kg of theophylline. 
The results of enzymic determination appear in Table 2. There was no 
significant change in phosphodiesterase activity as a result of adminis­
tering theophylline or histamine. These findings indicate either: 1)
the vivo dog stomach is not a suitable preparation to measure phospho­
diesterase inhibition, or 2) phosphodiesterase is not inhibited _in vivo.
The phosphodiesterase activities assayed from the biopsies ob­
tained in 2 experiments with papaverine are shown in Table 3. No con­
sistent change in enzymic activity was observed in either animal after
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.TABLE 1
CONTROL STUDY OF GASTRIC PHOSPHODIESTERASE IN VIVO
Gastric Phosphodiesterase Activity 
(moles of inorganic phosphate/mg protein-min X 10-9)
Saline
No. of \Min -30 0 f +15 +30 +60
Experiment
1 2.9 3.0 3.2 3.8 3.1
2 5.0 4.2 4.2 5.3 -
3 3.3 4.8 4.2 3.3
4 3.9 4.0 3.6 3.1 -
5 - 4.9 5.1 4.3 4.6
6 6.8 5.0 6.3 6.0 6.2
X + S.E. 4.4 + 0.7 4.3 + 0.3 4.5 + 0.6 4.4 + 0.4 4.3 + 0.7
TABLE 2
GASTRIC PHOSPHODIESTERASE ACTIVITY IN RESPONSE TO INTRAVENOUS 
ADMINISTRATION OF THEOPHYLLINE AND HISTAMINE
(moles
Gastric Phosphodiesterase Activity 
of inorganic phosphate/mg protein-min X 10-9)
No. of 
Experiment
\Mln -30
Theophylline 
(0.016 gm/kg)
0 +5 +15 +30 +60 +75
Histamine 
(30 ng/kg-hr)
+90 +120
+
+150
1 4.4 4.6 3.8 4.2 4.6 4.7 4.2 5.0 4.2 5.2
2 3.9 3.3 6.2 3.9 4.4 3.2 4.5 4.3 2.5 3.2
3 3.4 2.2 3.3 4.4 2.0 3.0 3.4 - 2.1 3.2
4 4.4 3.4 3.7 3.2 5.1 2.4 3.7 3.6 3.8 3.2
5 1.9 - 2.5 2.3 1.9 2.2 1.9 3.0 2.9 2.2
X + S.E. 3.6+0.5 3.4+0.5 3.9+0.6 3.6+0.4 3.6+0.7 3.1+0.4 3.5+0.5 3.9+0.4 3..1+0.4 3.4+0.5
-j
o
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TABLE 3
GASTRIC PHOSPHODIESTERASE ACTIVITY IN RESPONSE TO INTRAVENOUS 
ADMINISTRATION OF PAPAVERINE AND HISTAMINE
\ Gastric Phosphodiesterase Activity (moles of inorganic phosphate/mg protein-min, X 10-9)\ Papaverine (6 mg/kg) Histamine (30 pg/kg-hr)
No.\ 
of \Min 
Experi- \
ment
-30 0 +5 +15 +30
r
+60 +75 +90 +120
1 4.2 3.2 3.7 4.5 4.1 4.2 4.4 3.5 3.9
2 4.2 4.0 4.1 3.8 3.9 4.7 3.9 4.1 4.3
X 4.2 3.6 3.9 4.1 4.0 4.5 4.2 3.8 4.1
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administration of papaverine or histamine. These results support the 
preceding findings with theophylline that no significant change in the 
phosphodiesterase activity as a result of intravenous administration of 
the phosphodiesterase inhibitor and histamine.
Gastric Phosphodiesterase Activitv and Acid 
Secretorv Response to Intraarterial 
Administration of Papaverine 
and Theophvlline
Nine dogs were used for this study, 6 for the experiments with 
papaverine and 3 for those with theophylline. Two doses of papaverine 
were employed, 1.5 and 3.0 mg/kg-10 min infused for 20 min. In 3 exper­
iments with papaverine the second dose was continued for 40 min. No se­
cretion was initiated by papaverine in any experiment. The phosphodi­
esterase activities assayed from the biopsies taken in each experiment 
are shown in Table 4, There were no significant changes in enzymic ac­
tivity as a result of infusing papaverine, except at 60 min where sample 
size was too small to be meaningful. These results indicate that in­
creasing local concentrations of the phosphodiesterase inhibitor, papa­
verine, by intraarterial infusion fails to initiate gastric secretion in 
the dog.
In 3 animals, theophylline was infused intraarterially into the 
stomach segment in 3 graded doses (2.0, 4.0 and 8.0 mg/kg-10 min). De­
spite a considerable increase in drug concentration in the local area, 
neither was acid secretion initiated nor was phosphodiesterase activity 
affected (Table 5). These results support previous findings with papa­
verine.
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TABLE 4
GASTRIC PHOSPHODIESTERASE ACTIVITY IN RESPONSE TO 
INTRAARTERIAL ADMINISTRATION OF PAPAVERINE
\  Gastric Phosphodiesterase Activity 
\  (moles of inorganic phosphate/mg protein-min x 10“ )^
No. of NMin 
Experimental
-30 0
Rates of papaverine infusion 
(mg/kg-10 min)
1.5 3.0 3.0
X .L X
+20 +40 +60
1 3.3 3.9 3.8 3.7
2 - 3.5 3.3 2.9
3 3.6 4.4 4.5 3.8 3.4
4 4.9 4.9 5.2 4.3 2.9
5 3.7 4.0 4.4 4.2 4.2
6 3.4 3.8 3.8 3.5
X + S.E. 3.8 ± 0.3 4.1 ± 0.2 4.2 + 0.3 3.7 + 0.2 3.5 + 0.4
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TABLE 5
GASTRIC PHOSPHODIESTERASE ACTIVITY IN RESPONSE TO 
INTRAARTERIAL ADMINISTRATION OF THEOPHYLLINE
\  Gastric Phosphodiesterase Activity 
\  (moles of inorganic phosphate/mg protein-min x 10” )^
No. of \ 
Experiment
Min -30 0
Rates of theophylline infusion 
(mg/kg-10 min)
2.0 4.0 8.0 
i i
+20 +40 460
1 3.0 3.6 3.2 3.9
2 3.5 3.7 4.3 3.6 3.4
3 4.8 5.3 5.0 5.4
X + S.E. 3.8 + 0.5 4.2 + C1.6 3.8 + 0.6 4.2 + 0.4 4.4 + 1.0
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In Vivo Effect of Histamine on Canine Gastric 
Mucosal Adenvl Cyclase Activitv 
and Acid Secretion
Results of experiments in 4 dogs are shown in Figure 6. During 
the control period (before infusing histamine) no spontaneous acid secre­
tion was observed. The adenyl cyclase activity assayed from the control 
biopsies gave a mean value of 7.2 + 1.9 x 10” moles of cyclic AMP per 
mg of dry weight of muscosal tissue (expressed in the graph as p moles/ 
mg). Infusion of histamine (30 pg/kg-hr) stimulated gastric secretion 
which reached a peak between 120 and 150 min with a secretory rate of 
0.16 + 0.03 mEq/30 min. Enzymic activities obtained from 150-min biop­
sies gave a value of 6.1 +1.1 p moles/mg. Acid secretion showed a 
slight decline in the last collection interval. Biopsies taken immedi­
ately prior to the termination of histamine infusion yielded similar ac­
tivities to preceding biopsies with a mean value of 6.7 + 0.8 p moles/mg. 
No significant difference was found among enzyme activities in biopsies 
taken at the 3 time periods. When the enzymic preparations from 3 of 4 
control biopsies were assayed in the presence of 10“  ^M NaF, a large in­
crease in all activities was measured (44.7 + 2.5 p moles/mg). These 
findings indicate that canine mucosal adenyl cyclase was activated by 
fluoride but not by doses of histamine which stimulated secretion.
In Vitro Effect of Histamine on Canine 
Gastric Adenvl Cyclase Activitv
Figure 7 presents an jjn vitro experiment in which tissue was in­
cubated for 40 min with a wide range of histamine concentrations and one 
concentration of NaF in a buffer medium containing 0.5 mM C^^-ATP with a 
specific activity of 1.0 p.ci/O.1 jjmole. The activities of the enzyme were
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plotted against the concentrations of the test substances on semi-log­
arithmic paper. All samples were duplicated except the one at 10"^ M 
histamine. Two identical symbols at each concentration represent the 
duplicated values. In all concentrations studied (lO“ ,^ 5 x 10“ ,^ 10“^ ,
5 X 10”^ , 10“^ and 10“  ^M), histamine caused no appreciable change in 
adenyl cyclase activity from control values (at 0 concentration). By 
contrast, NaF at 10“^ M caused an approximate 20-fold i crease in adenyl 
cyclase activity from the basal level. The results of this experiment 
support the preceding observations in vivo that histamine did not stimu­
late dog gastric adenyl cyclase.
When mucosal adenyl cyclase was investigated at 2 different in­
cubation times, 10 and 20 min, in 5 identical experiments, a time-response 
curve of enzymic activity was found with NaF stimulation, whereas adenyl 
cyclase appeared unresponsive to histamine stimulation at two concentra­
tions studied, 10“^ and 10"^ M. These results are shown in Figure 8. In 
the presence of fluoride, the amount of cyclic AMP produced (92.3 + 19.9 
p moles/mg) was 10-fold greater at 20 min compared with its control (with­
out any testing substance) at the corresponding time (8.7 + 1.2 p moles/ 
mg). At 10 min, the amount of cyclic AMP formed with fluoride was about 
5 times greater than the control value (56.7 + 9.9 vs 8.8 + 1.5 p moles/ 
mg). In contrast to the striking effect of NaF, histamine at 10"'^  and 
10“  ^M resulted in activities similar to the controls. With histamine at 
10"^ and 10“3 M, the enzyme produced 7.7 +1.2 and 7.0 + 1.9 p mole/mg 
respectively at 10 min, and 9.3 + 1.7 and 7.8 + 1.0 p mole/mg at 20 min. 
These values were not significantly different from control values at 10 
and 20 min, whereas the effects of fluoride were significant at both
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times. These findings indicate that histamine does not activate canine 
gastric mucosal adenyl cyclase in vitro.
The effect of histamine and fluoride on gastric adenyl cyclase 
activity was investigated further in an assay system with twice the 
amount of substrate as used previously. Results from 5 experiments ap­
pear in Table 6. Fluoride consistently stimulated adenyl cyclase with a 
mean value of 103.0 + 5.8 p moles/mg, which was more than 4-fold greater 
than the control. 10“  ^M histamine failed to stimulate the enzyme (in 
fact, all values with histamine were slightly lower than their correspond­
ing controls). These findings indicate that histamine did not increase 
adenyl cyclase activity of the dog stomach _in vitro.
In the final set of experiments examining the in vitro effect of 
histamine on canine gastric adenyl cyclase, enzymic activity was com­
pared in 2 situations: histamine plus NaF versus NaF alone. Results ap-
pear in Table 7. Fluoride alone at a concentration of 5 x 10" M acti­
vated adenyl cyclase to a mean activity of 81.7 + 5.4 p moles/mg (more 
than 3 times control values). This was not the maximal capacity of the 
enzyme because in the same experiments, NaF at 10”  ^M activated the en­
zyme to a higher level (llO + 4.99 p moles/mg). When the enzyme was as­
sayed in the presence of the combination of 5 x 10"^  M NaF and 10“  ^M 
histamine, mean activity was not significantly different from that with 
5 X 10" M NaF alone. These findings support the previously described 
in vitro experiments on the effect of histamine on adenyl cyclase in the 
stomach.
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TABLE 6
IN VITRO EFFECT OF HISTAMINE AND SODIUM FLUORIDE ON GASTRIC 
ADENYL CYCLASE ACTIVITY IN CANINE MUCOSA*
Adenyl Cyclase Activity 
(p moles cyclic AMP formed/mg tissue)
\\Treatment
Experiment^v Control
Histamine Sodium Fluoride 
(10-3 M) (10-2 M)
1
[21.43]
[28.38] 24.91
il6.95'
.20.24* 18.60
] 98.88] 
. 90.93] 94.91
2
[20.68]
[l8.34j 19.51 :i?:28] 18.54
] 94.561 
. 79.72] 87.14
3
[16.98]
[12.84] 14.91
;i4.22'
.11.62] 12.92
]112.62] 
. 90.38] 101.50
4
[30.90]
[36.06] 33.48
]37.60'
.26.70] 32.15
117.10]
]119.56] 118.33
5
[26.88]
[22.96] 24.90
.18.88'
.18.08] 18.48
]120.08]
.106.60] 113.34
X + S.E. 23.54 + 3.11 20.13 + 3.19 103.00 + 5.75
*C^^-ATP concentration in the assay system was 1 mM with a spec­
ific activity of 0.5 pc/O.l pmole. Incubation time for all samples was 
10 min.
Duplicates of each sample are shown in the brackets. The average 
of the duplicates is outside the brackets.
TABLE 7
EFFECT OF HISTAMINE, SODIUM FLUORIDE AND THE COMBINATION ON GASTRIC 
ADENYL CYCLASE ACTIVITY OF CANINE MUCOSA IN VITRO
Adenyl Cyclase Activity 
(p moles cyclic AMP formed/mg tissue)
Treatment
Experiment
Control Histamine (10-3 M)
NaF NaF (5x10-3 M) NaF
(5x10-3 M) + Histamine (10-3 M) (i0"2 M)
X + S.E.
;i6.98]
.12.84] 14.91
[14.22"
[11.62; 12.98
;70.06^
.72.68; 71.27
.30.90]
.36.06] 33.48
[37.60'
[26.70; 32.15
;81.18'
.90.28; 85.73
26.88]
.22.96] 24.92
[18.88'
[I8.O8; 18.48
.87.60'
;89.64; 88.62
24.43 + 5.37 21.20 + 5.70 81.87 + 5.37
;92.20]
.63.62]
[72.50
[82.52
75.88
58.36
77.91
78.01
[112.62] 
[ 90.38]
[117.10]
[119.56]
67.12 
74.34 + 3.61
120
106
101.50
118.33
.08]
.60] 113.34 
111.00 + 4.99
Duplicates are shown in the brackets. The average of the duplicates is outside the brackets. 
Incubation time for all samples was 10 min.
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Effect of Histamine and NaF on Gastric Adenvl 
Cyclase Activitv of Guinea Pig 
Stomach in Vitro
The enzymic activity was determined with the same analytic 
method used in the canine enzyme analyses. The results appear in Table 
8. Fluoride stimulated the adenyl cyclase activity about 4-fold compared 
with controls. In addition, guinea pig gastric adenyl cyclase responded 
to histamine. The activities of the enzyme with either concentration of 
histamine were consistently higher than corresponding control activities 
by about 20 to 40^. The activities resulting from the 2 concentrations 
of histamine were not clearly different from one another. These findings 
correspond to a report in the literature (Perrier and Laster, 1970) and 
indicate that the assay used in here is capable of detecting changes in­
duced by histamine in another species.
Secretorv and Hemodynamic Responses of Canine Stomach 
to Arterial Infusion of Dibutvrvl Cyclic AMP
In 3 experiments in different dogs gastric secretory rate and 
arterial inflow were measured in response to infusion of dibutyryl cy­
clic AMP intraarterially. Blood flow was measured with an electromag­
netic blood flow meter. Dibutyryl cyclic AMP was infused following the 
control period at a dose of 0.1 mg/kg-min. At the end of 30 min after 
the beginning of the infusion, the dose was doubled by doubling the in­
fusion rate. Since the higher infusion rate was only 0.068 ml/min and 
arterial blood flow to the stomach flap was at least 1.5 ml/min, the in­
fused volume per se was unlikely to cause any significant effect on the 
blood flow. Table 9 shows the responses during each experimental period. 
The numbers in the parentheses represent the experiments performed. The
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TABLE 8
IN VITRO EFFECT OF HISTAMINE AND SODIUM FLUORIDE ON GASTRIC 
ADENYL CYCLASE ACTIVHY OF GUINEA PIG
\  Adenyl Cyclase Activity
\  Incubation 
\Time (min) 0 5 10
Treat- \  
ments \ Experiment 3 Experiment 3 Experiment 3
Control
[0.33]
[0.58] 0.46
[ 9.51] 
[ 8.53] 9.02 UoiS] 10-73
Histamine 
(5x10-5 M)
[0.23]
[0.53] 0.38
[11.27]
[11.92] 11.60
[14.16'
[14.06] 14.11
Histamine 
(10-4 M)
[0.46]
[0.55] 0.51
[11.39]
[10.72] 11.06
[13.55'
[13.44] 13.50
Sodium 
Fluoride 
(10-2 M)
[0.231
[0.83] 0.53 — — — — — — — — — —
[33.55'
[46.36] 39.96
Values in the brackets are duplicates of each sample. The aver­
age of the duplicates is shown outside the brackets.
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TABLE 8— Continued
(p moles of cyclic AMP formed/mg tissue)
20 40
Experiment 3 Experiment 2 Experiment 1 Experiment 2
L 8.81] 
[10.37] 9.60
[35.10]
[36.72 35.91 [18.42] 16.26
I 33.30]
L 30.12] 31 -7
[13.14]
[15.17] 14.16
[49.45]
[43.70] 46.58
[20.50" 
[18.ob; 19.29 i 42-38
[12.24]
[10.93] 11.59
[46.42]
[39.54] 42.98
L19.311
[21.40] 20.36 L 39.‘6s] 39.89
---- ---- ---- ----
[74.79'
[59.84] 67.32 [125:30] 126.75
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TABLE 9
EFFECT OF INTRAARTERIAL INFUSION OF DIBUTYRYL CYCLIC AMP 
ON SECRETORY AND HEMODYNAMIC RESPONSES 
OF CANINE STOMACH
Condition
Acid
Secretory
Rate
Blood Flow 
{% Change from 
first control 
period)
Arterial 
blood pressure 
(mm Hg)
Exp.l Exp. 2
First 0 (3) 0 0 128 + 7 (3)
Control 0 (3) 0 0 128 + 7 (3)
Dibutyryl
Cyclic AMP 0 (3) —  —  —  — +25.9 133 + 4 (3)
(O.l mg/kg-min) +53.3 +77.8 131 + 3 (3)
Dibutyryl
Cyclic AMP 0 (3) +73.3 +88.9 135 + 3 (3)
(0.2 mg/kg-min) +73.3 +88.9 133 + 2 (3)
Final 0 (3) 0 +44.4 130 + 3 (3)
Control 0 (3) 0 +18.5 130 + 3 (3)
The number of experiments are shovn in parentheses.
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arterial blood pressures are expressed as the means + standard errors of 
3 experiments. Arterial blood flows in two experiments are shown in the 
middle column in terms of percentage changes from the values measured at 
the end of the first control period. The flow measurements were obtained 
every 30 rain in two control periods and every 15 min during the infusion 
of dibutyryl cyclic AMP.
No acid secretion was found in either control period or during 
the 2 dibutyryl cyclic AMP infusion periods. The infusion of the cyclic 
AMP derivative did not cause any significant change in arterial blood 
pressure. However, the drug did induce large increases in arterial blood 
flow to the stomach segment. The increases appeared in 15 min following 
the start of infusion of dibutyryl cyclic AMP. The flow began to level 
off at 15 min after the start of the second dose. The largest magnitude 
of the increases was 73.3% in one experiment and 88.9% in the other. 
Following the termination of the infusion, blood flow returned toward 
the original level found in the first control period. These findings 
indicate that direct intraarterial infusion of the membrane permeable 
derivative of cyclic AMP does not initiate gastric secretion, although 
gastric blood flow is increased.
CHAPTER IV 
DISCUSSION
Since Sutherland and Rail (l958) discovered the cyclic nucleo­
tide phosphodiesterase in beef heart, it has been subsequently shown that 
almost all animal tissues studied contain this enzyme. Methylxanthines 
have been recognized as standard inhibitors of the enzyme. Adding these 
drugs to various tissue in vitro inhibited the phosphodiesterase activ­
ity (Sutherland and Rail, 1958; Butcher and Sutherland, 1962; Hynie 
et ad., 1966; Cheung, 1966) and potentiated or mimicked the cyclic AMP 
mediated effects of various hormones (Hynie ^  al_., 1966; Orloff and 
Handler, 1962; Handler et , 1965; Rail and West, 1963; Butcher et al.. 
1965). Papaverine was recently found also to be a potent inhibitor of 
phosphodiesterase in a number of tissues in vitro (Iriner et li., 1970; 
Kukovetz et , 1969; O'Dea et , 1970). It has been well established 
that theophylline inhibits phosphodiesterase competitively (Butcher and 
Sutherland, 1962). The kinetics of papaverine inhibition of the enzyme 
has not yet been delineated. According to Triner et (l970) the higher 
inhibitory effect of papaverine on phosphodiesterase from rat uterine 
muscle was associated with a lower concentration of the substrate (cyclic 
AMP) and vice versa; thus, papaverine seems also to be a competitive in­
hibitor of phosphodiesterase.
Although theophylline and papaverine inhibited phosphodiesterase
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from various tissues, their effect on gastric mucosal phosphodiesterase 
has not yet been reported. Therefore, the first experiments of the pres­
ent investigation were directed toward testing the effect of these drugs 
on cyclic phosphodiesterase in canine gastric mucosa. The results showed 
that both theophylline and papaverine inhibited the enzyme. Based upon 
the dose response curve (Fig. 2), concentrations of theophylline exceed­
ing 1.56 mM caused a much flatter slope than those below this concentra­
tion. The flat portion of the curve indicates a lesser susceptibility 
of gastric phosphodiesterase to theophylline as compared with the obser­
vations which Butcher and Sutherland (l962) reported in other tissues of 
the dog. The difference in the concentration of substrate (cyclic AMP) 
used in the 2 assay systems also explained partially the smaller effect 
of the drug on the gastric enzyme. In the case of papaverine, a dose 
response curve (Fig. 3) with a much steeper slope was found as compared 
with theophylline. 1.25 mM papaverine decreased the gastric phosphodi­
esterase activity by 90%. On a molar basis, this inhibition is about 
30% greater than that of theophylline on phosphodiesterase of beef heart, 
despite a much higher substrate concentration in the present assay.
For in vivo studies with intravenous administration, the doses 
of the phosphodiesterase inhibitors were chosen based on a series of 7 
pilot experiments, 4 for theophylline and 3 for papaverine. The highest 
dose which did not cause more than a 30% decrease in blood pressure was 
used in the experiments described in this thesis. The doses of 16 mg/kg 
and 6 mg/kg for theophylline and papaverine respectively was finally se­
lected. With these 2 doses, both theophylline and papaverine failed to 
cause the gastric segment to secrete, although they potentiated hista-
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mine-stimulated acid secretion (Figs. 4 and 5). This observation essen­
tially confirmed the findings by other investigators (Robertson et al.. 
1950). From the standpoint of Harris's cyclic AMP hypothesis, there 
could be several explanations for these findings: 1) The local concen­
tration of the phosphodiesterase inhibitors may only inhibit the gastric 
phosphodiesterase activity to such an extent that cyclic AMP accumulation 
would not be great enough to initiate the secretory process, but would 
be sufficient to potentiate histamine-stimulated acid secretion; 2) The 
phosphodiesterase activity in gastric secretory cells was inherently low 
or existed in vivo in an inactive state, as speculated by Cheung (l970). 
Further inhibition of the enzyme by an exogenous inhibitor would, there­
fore, at best contribute more cyclic AMP to produce a potentiating ef­
fect on acid secretion; 3) Canine parietal cell membrane might have a 
particularly poor permeability for methylxanthines and papaverine. This 
low permeability would largely limit the quantity of the drugs penetrat­
ing cell membrane; and 4) Increased concentrations of intracellular cy­
clic AMP are not essential for initiation of secretion by the stomach.
Although the permeability factor could explain the species dif­
ference to methylxanthines, it is difficult to be tested. Whether phos­
phodiesterase in the canine mucosa exists in an inhibited state is like­
wise untestable, because were it true, the in vivo inhibiting condition 
would not be maintained in the enzyme assay system in vitro. In other 
words, the enzyme would be released from its normal unfavorable condition 
when the enzyme was assayed. A comparison of phosphodiesterase activi­
ties among various tissues assayed by different investigators is diffi­
cult because of the differences in assay systems used. Butcher and
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Sutherland (l962) have reported a survey of phosphodiesterase activity 
in a variety of canine tissues except gastric mucosa. In a rough compar­
ison between the activity found in gastric tissue with the findings of 
Butcher and Sutherland, gastric mucosal phosphodiesterase activity might 
be classified as one of the lowest. Nevertheless this does not permit 
the conclusion that the low activity of phosphodiesterase found in dog 
gastric mucosa accounts for the failure of theophylline and papaverine 
to stimulate secretion, e=p^"ially in the absence of information about 
the phosphodiesterase activity of gastric mucosa in those species which 
respond to methylxanthines by secreting acid.
In order to test the first possible explanation, another ap­
proach to the problem was utilized. By virtue of the stomach flap prep­
aration, it was feasible to infuse drugs continuously into an artery 
which leads to the stomach segment, upon considering that the volume 
rate of the infusion to the artery and the solubility of the drugs in 
saline were both limited, 2 doses of papaverine (l.5 and 3.0 mg/kg-10 
min) and 3 doses of theophylline (2, 4 and 8 mg/kg-10 min) were chosen 
for the selective intraarterial infusion. Each dose was infused 20 min. 
The quantity of each drug reaching the mucosal tissue was much greater 
than that which could be achieved by intravenous injection. The results 
showed that in spite of this large increase in the local concentration 
of the drugs delivered to the stomach, neither theophylline nor papaver­
ine stimulated acid output. This finding rendered the first explanation 
unlikely.
Phosphodiesterase activities assayed from the tissue biopsies 
taken from in vivo experiments with either intraarterial or intravenous
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administration of the drugs did not reveal enzyme inhibition (Tables 2-5). 
This failure to detect inhibition of phosphodiesterase in vivo is not to­
tally unusual and has been reported in other tissues by other investiga­
tors. Verniko-Darrellis and Harris (l968) showed that phosphodiesterase 
from rat heart and brain was significantly inhibited in the presence of 
methyixanthine in an hi vitro assay system, but pretreating the animals 
with caffeine or theophylline did not cause reduction of in vivo enzymic 
activity in these tissues. One of the possible reasons for this occur­
rence would be the competitive inhibition of methylxanthines and papaver­
ine which then permits competition for the catalytic site(s) with the 
substrate (cyclic AMP). In the in vivo system, an extremely low level 
of cyclic AMP in the cell allows a better chance for inhibitors to occupy 
the binding site(s) on the enzyme, thereby allowing inhibition to occur 
easily. sVhen phosphodiesterase was assayed from biopsy samples, the con­
dition was different, because the inhibitors in the tissue sample were 
diluted and the high concentration of exogenous cyclic AMP which was used 
as the substrate restricted the opportunity for inhibitors to gain access 
to the critical site(s) on the enzyme. Furthermore, the binding force 
between the inhibitors and the enzyme does not seem to be strong; this 
weak binding was demonstrated in one of the preliminary experiments in 
which the enzyme was dialyzed against the buffer solution after being 
incubated with a high concentration of theophylline ijn vitro. The ac­
tivity of the dialyzed enzyme was found to return to the control level 
(without incubation with theophylline, but with dialysis). This observa­
tion indicated that the bound inhibitors on the enzyme in vivo could be 
easily released from the binding site(s) during the in vitro assay pro­
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cedure and replaced with the substrate. In the light of the preceding 
considerations the failure to detect inhibition of phosphodiesterase 
from the mucosal tissue pretreated with enzymic inhibitors in vivo does 
not necessarily mean that no inhibition occurred with the iri vivo system.
The failure of phosphodiesterase inhibitors, theophylline and 
papaverine to initiate gastric secretion and the potentiation by these 
drugs of histamine-stimulated acid secretion were clearly observed in 
this investigation. Should the potentiating effect of the drugs derive 
from their ability to inhibit phosphodiesterase activity in gastric mu­
cosa (thereby increasing cyclic AMP accumulation in the parietal cells) 
there must be another more powerful mechanism in the parietal cells to 
generate sufficient amounts of cyclic AMP to initiate the acid secretory 
process (as with histamine alone). Alternatively, one could conclude 
that accumulation of cyclic Af.'iP is not a necessary requisite for secre­
tion. A reasonable speculation would be that secretagogues, like hista­
mine, activate the cyclic AMP producing system (adenyl cyclase) on the 
parietal cell membrane. To test this possibility, the effect of hista­
mine on gastric adenyl cyclase activity was measured.
The gastric adenyl cyclase study was mainly composed of two por­
tions: ^  vivo and in vitro effects of histamine on the enzymic activ­
ity. The results of the jjo vivo experiments showed that histamine caused 
the gastric mucosa to secrete acid but did not affect the adenyl cyclase 
system (Fig. 6). The adenyl cyclase activity in the gastric mucosa was, 
therefore, independent of the rate of acid secretion stimulated by hista­
mine. The effect of histamine on canine gastric adenyl cyclase was ex­
amined directly in a variety of _in vitro assay systems. All results ob­
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tained (Figs. 7 and 8; Tables 6 and 7) supported the jji vivo finding. 
Therefore, based upon both in vivo and in vitro studies of adenyl cy­
clase, it was concluded that histamine did not stimulate canine gastric 
mucosal adenyl cyclase activity. Adenyl cyclase in the guinea pig stom­
ach appeared different from that of the dog. Guinea pig mucosa responded 
to histamine of either 5 x 10”  ^M or 10"^ M (Table S). This observation 
was in agreement with the findings reported by Perrier and Laster (l970) 
and Nakajima et (l97l). It thus indicated that a species difference 
exists in the response to histamine by gastric adenyl cyclase, although 
histamine stimulates the stomachs of both species to secrete acid 
(Shoemaker et ^ . , 1964). Eased upon these findings it seems untenable 
to hold that gastric adenyl cyclase is a major source of cyclic AMP re­
quired by gastric secretagogues to stimulate secretion.
Beside the adenyl cyclase system, another possible mechanism 
within the contact with the cyclic AMP hypothesis for initiating acid 
secretion would be the inhibition of phosphodiesterase in parietal cells 
by the secretagogues. In canine stomach, either methylxanthines or pa­
paverine might inhibit phosphodiesterase to a small extent. The major 
inhibition on the enzyme might be accomplished by histamine or other 
physiological acid stimulants. However, this did not appear to be true. 
In 2 experiments, canine gastric phosphodiesterase preparation was as­
sayed in the presence of histamine at 10"^, 10"^ and 10"^ M; the enzymic 
activity was not affected by histamine at any concentration studied. Be­
sides, it was reported by Amer and McKinney (l970) that both cholecysto- 
kinin (CCK), a weak acid stimulant and pentagastrin, a strong acid secre- 
tagogue, stimulated phosphodiesterase selectively in several tissues.
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including gastric mucosa in vitro. If this stimulation of phosphodies­
terase by acid secretagogues also happens in vivo, it would result in a 
decline in cyclic AMP concentration in gastric tissue concomitantly with 
an increase in acid secretion. The observation of phosphodiesterase 
stimulation by the secretagogues led the authors to put forward a hypo­
thesis that acid secretion was mediated by a decrease of intracellular 
cyclic AMP concentration in parietal cells.
Levine and his coworkers reported that intravenous infusion or 
injection of cyclic AMP inhibited histamine-stimulated acid secretion 
with a concomitant decrease in mucosal blood flow. They concluded that 
the hemodynamic effect of exogenous cyclic AMP in vivo may be responsible 
for acid inhibition (Levine et al., 1967). This explanation would imply 
that cyclic AMP may still play an intermediary role in parietal cells for 
acid secretory function, but the hemodynamic effect derived from large 
amount of exogenous cyclic AMP in the circulation overshadowed the nor­
mal stimulating effect on acid secretion. In addition to their specula­
tion, cyclic AMP is known as a poorly permeable compound for cell mem­
branes. It was reported that a high concentration of exogenous cyclic 
AMP failed to mimic the physiological effect of lipolytic hormones in adi­
pose tissue in vitro (Vaughan, 1960; Butcher et a%., 1965). Whether in­
fused cyclic AMP in the experiements of Levine et could pass through 
the cell membrane to reach the critical site(s) in the parietal cells was 
obviously questionable. In order to clarify these problems, the acid 
secretory response and arterial blood flow to the stomach flap were ob­
served with intraarterial infusion of dibutyryl cyclic AMP. It was found 
that dibutyryl cyclic AMP did not cause acid secretion under a circum-
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stance that arterial blood flow to the tissue was increased (Table 9). 
This suggested that cyclic AMP is a vasodilator and that the failure of 
dibutyryl cyclic AMP to evoke acid secretion from resting stomach tissue 
and inhibition of acid output from a secreting stomach by cyclic AMP can 
not be attributed to a decrease in arterial blood flow. The decrease in 
mucosal blood flow observed by Levine et _al. during the infusion of cy­
clic AMP is probably secondary to the decline in acid secretion. The in­
hibitory effect of cyclic AMP on histamine-stimulated acid secretion is 
not understood.
In view of the experimental results obtained in this investiga­
tion, gastric secretion in the dog was not initiated by administering 
gastric phosphodiesterase inhibitors nor by infusing the membrane-perme­
able derivative of cyclic AMP. Furthermore the gastric secretagogue, 
histamine, neither stimulated adenyl cyclase nor did it inhibit phospho­
diesterase. Thus the hypothesis of Harris and his collaborators that 
cyclic AMP is the intracellular mediator of acid secretion in the stomach 
was not supported.
CHAPTER V
SUMMARY
This research was addressed to evaluating the hypothesis of 
Harris and his associates thac cyclic AMP is the intracellular mediator 
of gastric acid secretion. Experimental approaches were designed to cor­
relate acid secretory function and enzymic activities which directly de­
termine the cyclic AMP concentration in the gastric mucosa. Both in vivo 
and ijn vitro experiments were performed in this investigation. All in 
vivo experiments were conducted on anesthetized dogs equipped with a gas­
tric chambered segment preparation.
Theophylline and papaverine were demonstrated to be effective 
inhibitors of gastric phosphodiesterase activity in vitro. Neither of 
these agents initiated acid secretion from the stomach flap when they 
were administered into the animals either intravenously or intraarteri- 
ally, although both drugs potentiated histamine-stimulated acid secre­
tion.
Effect of histamine on gastric adenyl cyclase activity was stud­
ied both in vitro and in vivo. When the enzyme was assayed from biopsies 
taken during the experiments with histamine infusion, it was found that 
the enzymic activity was not affected by histamine. In vitro, the effect 
of histamine on gastric adenyl cyclase was studied under the following
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conditions: l) a wide range of histamine concentrations; 2) two differ­
ent concentrations of the substrate (ATP) for the assay; 3) various in­
cubation times; and 4) with or without background stimulation by NaF.
Under all conditions, histamine failed to stimulate adenyl cyclase.
The possibility that histamine might inhibit gastric phosphodi­
esterase was tested by incubating the enzymic preparation with several 
concentrations of histamine. The results showed no inhibition of the 
enzymic activity by histamine.
The final set of experiments were conducted to examine the ef­
fect of exogenous cyclic AMP on acid secretion. In an attempt to assure 
an increase in the concentration of the cyclic compound in the parietal 
cells, membrane permeable dibutyryl cyclic AMP was infused intraarterially 
into the gastric mucosal tissue. No acid secretion was observed during 
or following the infusion. Since the total arterial blood flow to the 
stomach tissue was markedly increased, it is unlikely that the failure 
of acid secretion with exogenous cyclic AMP was attributable to ischemia.
In considère’’;'"^  of the findings presented in this dissertation- 
al investigation, the conclusion appears warranted that the cyclic AMP 
hypothesis of Harris and his associates is untenable. Rather, the ini­
tiation of gastric secretion in the canine stomach does not seem to de­
pend upon alterations in the activities of enzymes responsible for accu­
mulation of cyclic AMP.
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